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Bilirubin, a bichromophoric tetrapyrrole, binds to albumin with high affinity at a site 
located at or near loop 4 in subdomain HA. Bilirubin-albumin binding is stabilized by 
various noncovalent forces such as salt linkages, hydrogen bonds, aromatic TC-TC van der 
Waals attractions and hydrophobic interactions. The combination and topography of 
these binding elements dictate the three-dimensional shape and chirality of the bound 
pigment. In terms of the relative importance, salt linkages existing between carboxyl 
groups of bilirubin and E-NHJ groups of lysine residues in protein, are presimied to be 
more important. These lysine residues are believed to be buried in the protein 
interior having abnormal pK values. Although, involvement of internal lysine residues 
in bilirubin-albumin interaction has been shown in BSA, a detailed and careful 
investigation is lacking on other serum albumins. In order to understand the mechanism 
of bilirubin encephalopathy and to develop various preventive measures, selection of an 
animal is futile imless the animal albumin binds bilirubin in the similar manner as 
human albimain binds. In view of this, different mammalian serum albumins viz. human 
(HSA), rabbit (RbSA), goat (GSA), sheep (SSA) and buffalo (BuSA) serum albumins 
were selected and their conformational and bilirubin binding properties were studied 
after modifying the internal lysine residues with acetic anhydride, succinic anhydride 
and O-methylisourea. 
In order to modify the internal lysine residues, first the reactivity of completely or 
partially exposed lysine residues of these albimiins, was checked towards citraconic 
anhydride, a reversible modifier. A progressive increase in citraconylation was observed 
with the increase in citraconic anhydride concentration up to ~ 100 molar excess of 
anhydride over protein which sloped off at higher anhydride concentration. A 
comparison of these results suggested that in aU albumins, nearly 80±3% lysine residues 
were completely accessible to the modifier whereas remaining 20t3% were buried to 
different extent in the proteio interior and thus required higher anhydride concentration 
for their modification. These lysine residues were modified using a double chemical 
modification approach as described in Materials and Methods. All these derivatives 
(acetylated, succinylated and guanidinated), having ~10-13 internal lysine residues 
modified, were found to be homogeneous with respect to charge and size as judged by 
Seralose-6B gel chromatography and polyacrylamide gel electrophoresis. However, a 
slight increase in the anodic mobility was observed in some of the succinylated albumin 
derivatives. These derivatives were then characterized for their conformational and 
bilirubiQ binding properties using analytical gel filtration, circular dichroism (CD), 
fluorescence and absorption spectroscopy. 
As characterized by far-UVCD (MREssanm), no significant change was observed in 
the secondary structure of these albumins upon covalent modification of internal lysine 
residues. On the other hand, near-UVCD spectra of acetylated as well as succinylated 
derivatives showed a slight decrease in the MRE value both at 262 and 268 nm and a 
little increase in MRE above 280 nm. These alterations in the MRE were indicative of 
the change in the asymmetry of the proteiQ's aromatic amino acids' environment and / or 
disulfide bridges. The near-UVCD spectra of gnanidinated albumin derivatives were 
more or less similar to the one obtained with native albimiins. A slight increase in the 
ellipticity value between 280 and 300 nm in acetylated and succinylated derivatives can 
be ascribed to the immobilization of tryptophan side chain in a more hydrophobic 
environment which was in accordance witii the tryptophan fluorescence results in which 
a blue shift of about 9-11 nm in the emission maxima was observed in these derivatives. 
These results suggested that few acetyl or succinyl groups were incorporated onto tihose 
lysine residues which seem to be located in the close vicinity of tryptophan. Since the 
extent of blue shift and decrease in fluorescence intensity observed wilii HSA 
(containing a lone tryptophan-214 in subdomain HA) upon acetylation or succinylation 
were more or less similar to those observed with the same derivatives of other albumins, 
it was believed that change in the microenvironment was mainly confined to the 
tryptophan present in subdomain DA in these albumins. Although, all serum albumins 
showed an increase (5-8%) in Stokes radius upon succinylation, the effect of acetylation 
on the Stokes radius was seen only in some cases. Guanidination, on the other hand, did 
not result in any change in Stokes radius. Taken together, all these results suggested a 
slight alteration in the tertiary packing of different albumins upon acetylation and 
succinylation. Guanidination did not affect the conformation of protein to a measurable 
extent. 
Using fluorescence quench titration for the interaction of bilirubin with albumin and by 
fitting the data in Scatchard plot, a significant decrease (5-21 fold) in the value of 
association constant, Ka was noticed upon acetylation or succinylation of internal 
lysine residues in different serum albumins. On the other hand, guanidinated albumin 
derivatives showed more or less similar values of Ka as obtained with native albumins. 
Visible absorption spectra of bilirubin-albumin complexes were severely perturbed upon 
acetylation or succinylation. Nearly 20-30 % reduction in molar absorption coefficient 
(e) and a significant blue shift (10-20 nm) in the absorption maxima (A a^x) of various 
bilirubin-albumin complexes were noticed upon acetylation or succinylation of internal 
lysine residues of these albumins. On the other hand, guanidination showed littie 
changes in these properties. The intensity of both positive and negative CD Cotton 
effects (CDCEs) of the characteristic bisignate CD spectra of bilirubin-HSA and 
bilirubin-RbSA complexes was reduced to -50% to that of the original value upon 
acetylation or succinylation of internal lysine residues, though the shape and sign order 
of the bisignate CD spectra were identical to that observed with native albumins. 
Interestingly, characteristic monosignate CD spectra of bilirubin complexed with GSA, 
SSA and BuSA, were transformed to the bisignate CD spectra upon acetylation or 
succinylation of internal lysine residues. Guanidination, on the other hand, did not 
perturb the CD spectra of bilirubin-albumin complexes. These results suggested the 
predominance of salt linkage(s) contributed by internal lysine residue(s) in binding and 
dictating the three dimensional shape and chirality of bilirubin at high affinity site on 
different albumins. When probed by CD spectroscopy, bilirubin bound to acelylated or 
succinylated derivatives of GSA and SSA was rapidly switched over to native albumins 
but not vice versa, implying that salt linkage(s) provided stability to the native three 
dimensional conformation of the bound pigment. Chloroform efficiently transformed 
the monosignate CDCEs of bilirubin complexed with GSA, SSA and BuSA into 
bisignate CDCEs and inverted the bisignate CDCEs of bilirubin complexed with HSA 
and RbSA. Chloroform also severely decreased the intensity of both positive and 
negative CDCEs of bilirubin complexed with acetylated or succinylated derivatives of 
all albimiins which otherwise increased significantly in case of native as well as 
guanidinated albxunin-bilirubin complexes except bilirubin-RbSA complex where aUttie 
decrease in intensity was found. Further, except HSA derivatives, chloroform did not 
invert the CD spectra of bilirubiD complexed with acetylated or succinylated derivatives 
of other albumins. Alterations in the CD spectra of bilirubin complexed with 
guanidiaated derivatives were similar to native albimiin-bilirubin complexes, thus the 
existence of salt linkage(s) in bilirubin-albumin complexation seems to be crucial to 
bring about effective and efficient stereochemical changes of the boimd pigment by co-
binding of chloroform which seems to have at least one conserved binding site on 
different serum albumins that is shared with bilirubin. 
Photoinduced fluorescence enhancement of bilirubin bound to primary binding site on 
HSA was completely ceased upon acetylation or succinylation of internal lysine 
residues, though the pigment boimd to these derivatives in a folded conformation as 
revealed by retention of bisignate CD spectra, akin to that bound to HSA. Interestingly, 
when characterized by CD spectroscopy, a brief (1 minute) irradiation of bilirubin 
bound to acetylated or succinylated HSA derivatives under white fluorescent light, 
completely abolished the negative CDCEs while moderately affecting the intensity of 
positive CDCEs and shifling the band maxima slightiy towards blue region. On the 
other hand, 1 minute irradiation of bilirubin bound to native or guanidinated HSA under 
white fluorescent light, produced only a little decrease in the intensity of both positive 
and negative CDCEs. Similar changes were also noticed in the visible absorption spectra 
of bilirubin complexed with HSA and its derivatives. A brief (2 minutes) irradiation of 
an equimolar complex of bilirubin with either acetylated or succinylated HSA 
accompanied a rapid shift of-15 nm in the absorption maxima (Amax) towards shorter 
wavelength which continued up to 4-5 minutes and then became constant at 434/ 435 
nm. On the other hand, similar treatment of die complexes of bilirubin with either 
native or guanidiDated HSA derivative did not show any change in the absorption 
spectra. 
These photoinduced spectral modulations can not be ascribed to the binding of 
bilirubin to secondary low affinity sites as the CD spectrum of bilirubin bound to these 
derivatives showed complete inversion upon addition of chloroform which binds to 
subdomain HA in HSA where high affinity bilirubin binding site is located. Further, 
presence of chloroform reconciled the photoinduced alterations in the CD spectrum 
observed in its absence, suggesting that chloroform stabilized the bound ligand against 
7 
light but the fluorescence properties of bilirubin complexed with acetylated or 
succinylated derivatives remained unchanged. Guanidination of internal e-NH2 groups 
in HSA by 0-methylisourea did not alter the spectral properties of the bound ligand. 
These results suggest that salt linkage(s) existing between 8-NH2 groups of lysine 
residues in HSA and carboxyl groups of bilirubin, act(s) as a potential barrier during 
conformational rotation of the bound ligand assisted by photoactivation and their 
abolishment can alter the dynamics and stereoselectivity of the boimd pigment, a 
hitherto imnoticed implication of salt linkage(s) in bilirubin-HSA complex. 
ROLE OF INTERNAL LYSINE RESIDUES OF SERUM 
ALBUMINS IN BILIRUBIN BINDING AND 
CONFORMATIONAL STABILITY OF 
ALBUMIN-BOUND BILIRUBIN 
11 4, 
J 5* ^1 
®\ •«*,-/ / 
MOHAMMAD MUSHAHID KHAN 
A thesis submitted in fulfilment of the requirements for the 
degree of Doctor of Philosophy in Biotechnology of the 
Aligarh Muslim University, Aligarh 
2000 
T5409 
R^te rf Interift^ il Lysine R ^ i d u ^ ©f 
S^um Albumins; in Bilirubin Binding 
and C^nfi^rmational Stability of 
Albumin-Bound Bilirubin 
Date: 
Approved: 
Saad Tayyab, Supa •rnsor 
Mohammad Mushahtd Khan 
A th^iii submitt^ in fttlftlment of the requirements for 
the degree of Doctor of Philosophy in Biotechnology of the 
Aligiirh Muslim University 
AUGARH 
INTERDISCIPLINARY BIOTECHNOLOGY UNIT 
ALIGARH MUSLIM UNIVERSITY, ALIGARH-202 002 (INDIA) 
C^tifleat© 
1 certify that the work presented in the following pages has been carried out 
by Mr. Mohammad Mushahid Khan and that it is suitable for the award of 
Ph.D. degree in Biotechnology of die Aligarh Muslim University, Aligarh. 
/r. 
Saad Tayyab,""? h.D. 
Reader & Supervisor 
Phone 0091-571-401718, Fax 0091-571401081 E-mail btisamua@nde vsnl net in 
€^ftoo<ue& me ui<pm> ca/^e^ie/d 0*1^ im 7)te, 
C£dliaa^ oMtta/ifn Univewitu, 
CONTENTS 
Page No. 
ABSTTRACT' I 
ACKNOWl-lHeMlNris v i i i 
©EBICAHON X 
LIST'OF TABLES x i 
UST OF FKillRlS x i i 
INTROmiCTION 1 
MATHoAts Mm mwmmm 32 
/y | miTMMMS 32 
K PtGteMjm 32 
Z. tj^atttts usejd in bitttSt^ stufMm 32 
5* Meagents tis^d m gel deeiFeph&F&as 33 
4 Rmgeatsusiedmpj^etdm&stimM^mt 34 
fBi METMOm 36 
i» pM nmmuf&mmttsi 36 
2l Retemmmdmt GfpjF^tmn e^mwmtTQtimk 36 
^ P«^<tef:^hmiMsgeleteetwepJkm&siS(^PA€^J^ ^7 
4^ Gel ekrmmte^dipb^ ^^ 
Z Fbtmemmm sprnttmsi^p^ ^^ 
9L MMemtm bmSxtg slmSm ^^ 
9L CampeMa^ beseem natixe ami mtuB^ ^^ 
i(k J^eet €ifeMm&fmm &it tb& €B speet^a qfvmimts bi^mMiihftlbMmlm 47 
mmpksxes, 
Fm-fI¥€B 63 
Nem-U¥€B 63 
Tiiypt0ftk(ittfltimm&&a€& ^^ 
MekmtoBtsm ^^ 
Bilimkm Mndm^ studies- 7 4 
C&mpetiimM Bietweem na^e and m&difiei alktmtinfm M^ubm MnMm^ 9 6 
Ph&tmhemmt dhaagesi ^ fMKwukm Imuttd t(k MIM Qtid «l« eferlvallves; i o 6 
B]MJ€)€IIAPH¥ 123 
MST OF PAPIRS PmUSHm/' COMMIWICAllII 138 
B1€l€lt^II¥ 139 

Bilirubin, a bichromophoric tetrapyrrole, binds to albiunin with high affinity at a site 
located at or near loop 4 in subdomain IIA. Bilirubin-albumin binding is stabilized by 
various noncovalent forces such as salt linkages, hydrogen bonds, aromatic n-n van der 
Waals attractions and hydrophobic interactions. The combination and topography of 
these binding elements dictate the three-dimensional shape and chirality of the bound 
pigment. In terms of the relative importance, salt linkages existing between carbo?^l 
groups of bilirubin and E-NH2 groups of lysine residues in protein, are presumed to be 
more important. These lysine residues are believed to be buried in the protein 
interior having abnormal pK values. Although, involvement of internal lysine residues 
in bilirubin-albumin interaction has been shown in BSA, a detailed and careful 
investigation is lacking on other serum albimiins. In order to imderstand the mechanism 
of bilirubin encephalopathy and to develop various preventive measures, selection of an 
animal is futile unless the animal albxmiin binds bilirubin in the similar manner as 
human albumin binds. In view of this, different mammalian serum albumins viz. human 
(HSA), rabbit (RbSA), goat (GSA), sheep (SSA) and buffalo (BuSA) serum albumins 
were selected and their conformational and bilirubin binding properties were studied 
after modifying the internal lysine residues with acetic anhydride, succinic anhydride 
and 0-methylisourea. 
I I 
In order to modify the internal lysine residues, first the reactivity of completely or 
partially exposed lysine residues of these albumins, was checked towards citraconic 
anhydride, a reversible modifier. A progressive increase in citraconylation was observed 
with the increase in citraconic anhydride concentration up to -100 molar excess of 
anhydride over protein which sloped off at higher anhydride concentration. A 
comparison of these results suggested that in all albumins, nearly 80±3% lysine residues 
were completely accessible to the modifier whereas remaining 20±3% were buried to 
different extent in the protein interior and thus required higher anhydride concentration 
for their modification. These lysine residues were modified using a double chemical 
modification approach as described in Materials and Methods. All these derivatives 
(acetylated, succinylated and guanidinated), having -10-13 internal lysine residues 
modified, were found to be homogeneous with respect to charge and size as judged by 
Seralose-6B gel chromatography and polyacrylamide gel electrophoresis. However, a 
slight increase in the anodic mobility was observed in some of the succinylated albumin 
derivatives. These derivatives were then characterized for their conformational and 
bilirubin binding properties using analytical gel filtration, circular dichroism (CD), 
fluorescence and absorption spectroscopy. 
As characterized by far-UVCD (MRE222nm), no significant change was observed in 
the secondary structure of these albumins upon covalent modification of internal lysine 
residues. On the other hand, near-UVCD spectra of acetylated as well as succinylated 
derivatives showed a slight decrease in the MRE value both at 262 and 268 nm and a 
I l l 
little increase in MRE above 280 nm. These alterations in the MRE were indicative of 
the change in the asymmetry of the protein's aromatic amino acids' environment and / or 
disulfide bridges. The near-UVCD spectra of guanidinated albumin derivatives were 
more or less similar to the one obtained with native albimiins. A slight increase in the 
ellipticity value between 280 and 300 nm in acetylated and succinylated derivatives can 
be ascribed to the immobilization of tryptophan side chain in a more hydrophobic 
environment which was in accordance with the tryptophan fluorescence results in which 
a blue shift of about 9-11 nm in the emission maxima was observed in these derivatives. 
These results suggested that few acetyl or suceinyl groups were incorporated on to Ihose 
lysine residues which seem to be located in the close vicinity of tryptophan. Since the 
extent of blue shift and decrease in fluorescence intensity observed with HSA 
(containing a lone ttyptophan-214 in subdomain HA) upon acetylation or succinylation 
were more or less similar to those observed with the same derivatives of other albumins, 
it was believed fliat change in the microenvironment was mainly confined to the 
tryptophan present in subdomain HA in these albumins. Although, all serum albimiins 
showed an increase (5-8%) in Stokes radius upon succinylation, the effect of acetylation 
on the Stokes radius was seen only in some cases. Gxianidination, on the other hand, did 
not result in any change in Stokes radius. Taken together, all these results suggested a 
slight alteration in the tertiary packing of different albimiins upon acetylation and 
succinylation. Guanidination did not affect the conformation of protein to a measurable 
extent. 
IV 
Using fluorescence quench titration for the interaction of bilirubin with albumin and by 
fitting the data in Scatchard plot, a significant decrease (5-21 fold) in the value of 
association constant, Ka was noticed upon acetylation or succinylation of internal 
lysine residues in different serum albimiins. On the other hand, guanidinated albumin 
derivatives showed more or less similar values of Kg as obtained with native albumins. 
Visible absorption spectra of bilirubin-albumin complexes were severely perturbed upon 
acetylation or succinylation. Nearly 20-30 % reduction in molar absorption coefficient 
(e) and a significant blue shift (10-201^i)"inthe-absoiption maxima (Acax) of various 
bilirubin-albumin complexes were noticed upon acetylation or succinylation of internal 
lysine residues of these albumins. On the other hand, guanidination showed little 
changes in these properties. The intensity of both positive and negative CD Cotton 
effects (CDCEs) of the characteristic bisignate CD spectra of bilirubin-HSA and 
bilirubin-RbSA complexes was reduced to ~50% to that of the original value upon 
acetylation or succinylation of internal lysine residues, though the shape and sign order 
of the bisignate CD spectra were identical to that observed with native albumins. 
Literestingly, characteristic monosignate CD spectra of bilirubin complexed with GSA, 
SSA and BuSA, were transformed to the bisignate CD spectra upon acetylation or 
succinylation of internal lysine residues. Guanidination, on the other hand, did not 
perturb the CD spectra of bilirubin-albumin complexes. These results suggested the 
predominance of salt linkage(s) contributed by internal lysine residue(s) in binding and 
dictating the three dimensional shape and chirality of bilirubin at high affinity site on 
different albumins. When probed by CD spectroscopy, bilirubin bound to acelylated or 
succinylated derivatives of GSA and SSA was rapidly switched over to native albumins 
but not vice versa, implying that salt linkage(s) provided stability to the native three 
dimensional conformation of the bound pigment. Chloroform efficiently transformed 
the monosignate CDCEs of bilirubin complexed with GSA, SSA and BuSA into 
bisigpate CDCEs and inverted the bisignate CDCEs of bilirubin complexed with HSA 
and RbSA. Chloroform also severely decreased the intensity of both positive and 
negative CDCEs of bilirubin complexed with acetylated or succinylated derivatives of 
all albumins which otherwise increased significantly in case of native as well as 
guanidinated albumin-bilirubin complexes except bilirubin-RbS A complex where a litde 
decrease in intensity was found. Further, except HSA derivatives, chloroform did not 
invert the CD spectra of bilirubin complexed with acetylated or succinylated derivatives 
of other albumins. Alterations in the CD spectra of bilirubin complexed with 
guanidinated derivatives were similar to native albumin-bilirubin complexes, thus the 
existence of salt linkage(s) in bilirubin-albumin complexation seems to be crucial to 
bring about effective and efficient stereochemical changes of the bound pigment by co-
binding of chloroform which seems to have at least one conserved binding site on 
different serum albumins that is shared with bilirubin. 
Photoinduced fluorescence enhancement of bilirubin bound to primary binding site on 
HSA was completely ceased upon acetylation or succinylation of internal lysine 
residues, though the pigment bound to these derivatives in a folded conformation as 
VI 
revealed by retention of bisignate CD spectra, akin to tiiat bound to HSA. Interestingly, 
when characterized by CD spectroscopy, a brief (1 minute) irradiation of bilirubin 
bound to acetylated or succinylated HSA derivatives under white fluorescent light, 
completely abolished the negative CDCEs while moderately affecting the intensity of 
positive CDCEs and shifting the band maxima slightly towards blue region. On the 
other hand, 1 minute irradiation of bilirubin bound to native or guanidinated HSA under 
white fluorescent light, produced only a little decrease in the intensity of both positive 
and negative CDCEs. Similar changes were also noticed in the visible absorption spectra 
of bilirubin complexed with HSA and its derivatives. A brief (2 minutes) irradiation of 
an equimolar complex of bilirubin with either acetylated or succinylated HSA 
accompanied a rapid shift of-15 nm in the absorption maxima (A a^x) towards shorter 
wavelength which continued up to 4-5 minutes and then became constant at 434/ 435 
nm. On the other hand, similar treatment of the complexes of bilirubin with either 
native or guanidinated HSA derivative did not show any change in the absorption 
spectra. 
These photoinduced spectral modulations can not be ascribed to the binding of 
bilirubin to secondary low affinity sites as the CD spectrum of bilirubin bound to these 
derivatives showed complete inversion upon addition of chloroform which binds to 
subdomain HA in HSA where high affmity bilirubin binding site is located. Further, 
presence of chloroform reconciled the photoinduced alterations in the CD spectrum 
observed in its absence, suggesting that chloroform stabilized the bound ligand against 
V I I 
light but the fluorescence properties of bilirubin complexed with acetylated or 
succinylated derivatives remained unchanged. Guanidination of internal S-NH2 groups 
in HSA by 0-methylisourea did not alter the spectral properties of the bound ligand. 
These results suggest that salt linkage(s) existing between 8-NH2 groups of lysine 
residues in HSA and carboxyl groups of bilirubin, act(s) as a potential barrier during 
conformational rotation of the bound ligand assisted by photoactivation and their 
abolishment can alter the dynamics and stereoselectivity of the bound pigment, a 
hitherto imnoticed implication of salt linkage(s) in bilirubin-HSA complex. 
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Serum albumin is one of the members of a multigene family of proteins that includes a-
fetoprotein (AFP) and human group-specific component (Gc) or Vitamin D-binding 
protein (Carter & Ho, 1994). It is the major soluble protein constituent of the circulatory 
system having many vital physiological fiinctions and is chiefly responsible for the 
maintenance of blood pH. It also contributes -80% to the coUoid osmotic blood 
pressure (Figge etal.,1991). Serum albumin was recognized as a principal component of 
blood as early as 1839 (Ancell, 1839). Originally, the protein was referred to as 
'albumen', derived from the Latin word albus 'meaning white' after the white color of 
flocculant precipitates produced by various proteins. Because of its availabihty, low cost, 
stability and unusual ligand binding properties, serum albumin has been one of the most 
exhaustively studied and applied proteins in biochemistry as evident from several 
excellent reviews (Foster, 1960; Peters, 1970; 1980; 1984; 1985; 1992; Kragh-Hansen, 
1981; 1990; Carter & Ho, 1994) and a book (Peters, 1996) on serum albumin. 
The synthesis of albumin takes place in the liver as has been demonstrated in surviving 
slices of liver from many species (Peters & Anfinsen, 1950; Dancis et al, 1957; 
Hrrayama et al, 1959). A systematic analysis of the synthesis of nascent polypeptide 
chain, disulfide bonds formation and its delivery into endoplasmic reticulum and finally to 
other destinations has been made by Peters and his group (Peters, 1962a; 1962b; Peters & 
Peters, 1972; Peters & Reed, 1980; Peters & Davidson, 1982). In fetus, the synthesis of 
albumin starts by about 7 weeks (Kelleher e? «/., 1963;Gitlin&Boesman, 1966) and in 
early fetal circulation there is another protein, ai-fetoglobulin, of molecular weight 
65,000 which differs from albumin in amino acid composition and electrophoretic 
mobility (Bergstrand& Czar, 1956; Alpert era/., 1968). Albumin mRNA is comprised of 
2080 base pairs. Signal peptide, a stretch of 18 residues, is the first translated sequence 
which directs the growing peptide chain through the membrane of endoplasmic reticulum 
before being cleaved off and even before the completion of the RNA translation. The 
newly formed albumin called 'proalbumin' contains a stretch of a basic hexapeptide (Arg-
Qy-Val-Phe-Arg-Arg) attached to its amino terminal end (Urban etal, 1974). This leader 
peptide guides the polypeptide chain from endoplasmic reticulum to Golgi complex for 
proteolytic processing and secretion (Judah, 1983) and finally cleaved in the Golgi 
complex (secretory vesicles) before the release of albumin from the cell in its biologically 
active form. 
BistpBadtm aadimnmet 
Serum albunun is located in every tissue and bodily secretions. About 40% of the total 
albumin is found in the circulatory plasma (Peters, 1992) whereas remaining 60% resides 
about half in Adscera and half in muscle and skin (Rabilloud et al, 1988). Albumin is a 
major protein of tooth "enamelin" (Strawich & Glimcher, 1990) and is reported to occur 
intracellularly in developing brain tissue (Pineiro et al, 1982), nerve cells (Mata et al, 
1987) and both interstitially and intracellularly, in testis (Krishna & Spanel-Borowski, 
1990) where it may be produced as "testibumin" in the seminiferous tubular compartment 
(Cheng & Bardin, 1986). Albumin has also been recognized in milk (Phillippy & 
McCarthy, 1979), amniotic fluid (Bala et al, 1987) and mammary cysts (Balbin et al, 
1991). The albumin concentration in plasma in an average person is about 35-50 g/L, 
which declines slightly with age (Cooper & Gardner, 1989) and is lower in newborns 
(Cartlidge & Rutter, 1986) and as low as 20g/L in premature infants (Reading et al, 
1990). Albimiin is produced by tiie liver at a rate of 0.7 mg / g liver per hour (Peters, 
1985). About 4-5% of albumin is replaced by hepatic synthesis daily (Olufemi et al, 
1990). The turnover is first order with an average half-life of 19 days (Waldmann, 1977). 
The rate ofalbimiin degradation generally falls in malnourished states including diabetes 
(Peters, 1992). The albumin concentration in plasma is maintained through transcriptional 
control of the albumin gene by the anabolic hormones, insulin and somatotropin (Hutson 
et al, 1987). Albumin synthesis is also highly dependent upon the supply of dietary 
amino acids (Kaysen et al, 1989). 
Aitiiii0 acM ecmptsl^l^ '-Table 1 shows the amino acid composition of human (HSA), 
bovine (BSA), rat (RSA) and sheep (SSA) serum albumins. Albumins do not contain any 
carbohydrate or any other non-protein moiety, characterized by a low content of 
Table 1 
Amino acid compositions of human, bovine, rat and sheep serum albumins 
Amino acid 
Aspartic acid 
Asparagine 
Threonine 
Serine 
Glutamic acid 
Qutamine 
Proline 
Glycine 
Alanine 
Cystine /2 
Cysteine 
Valine 
Methionine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Histidine 
Lysine 
Tryptophan 
Arginine 
Total 
Humarf 
36 
17 
28 
24 
62 
20 
24 
12 
62 
34 
01 
41 
06 
08 
61 
18 
31 
16 
59 
01 
24 
585 
Bovine^ 
40 
14 
33 
28 
59 
20 
28 
16 
47 
34 
01 
36 
04 
14 
61 
20 
27 
17 
59 
02 
23 
583 
Rat'' 
33 
20 
34 
24 
57 
23 
29 
18 
61 
34 
01 
35 
06 
15 
56 
19 
26 
15 
53 
01 
24 
584 
Sheep 
44 
14 
30 
24 
56 
19 
29 
17 
51 
34 
01 
36 
04 
13 
62 
20 
27 
18 
60 
02 
22 
583 
"Peters, 1992; ''Carter & Ho, 1994 
isoleucine, methionine and glycine and contain either one (e.g. HSA and RSA) or two 
(e.g. BSA and SSA) tryptophan residues (Carter & Ho, 1994). Albumins have high 
content of cystine and charged amino acids, aspartic and glutamic acids, lysine and 
arginine (see Table 1) (Brown & Shocldey, 1982). There is a tendency towards higher 
isoleucine and methionine content with lower species (Peters, 1992). 
Ffiniafy strBdmrfe— Mammalian albumins contain -585 amino acids arranged in a single 
large polypeptide chain (Brown, 1975). Figure 1 shows the primary amino acid sequence 
of HSA. High percentages of sequence homologies have been found among different 
albumins being 76% between HSA and BSA (Peters, 1985); 76% between ESA (equine 
serum albumin) and HSA; 73% between ESA and BSA; 76% between ESA and RSA (Ho 
et al, 1993) and 61% among BSA, RSA and HSA (He & Carter, 1992). About 50% 
'conserved residues are found in all known albumin sequences (Carter & Ho, 1994). There 
are 17 disulfide bridges in albumin and the whole molecule is characterized by a unique 
arrangement of double loops that repeat as a series of triplets. They are arranged in a 
series of nine loop-link-loop structures centered around eight sequential Cys-Cys pairs 
(Figure 1). The conformations of the disulfides are primarily gauche-gauche-gauche 
(CPi-SrS2-CP2) with torsion angles clustering around ± 80° (He & Carter, 1992). The 
repetition of these loops in a triplet fashion of large-small-large can group these loops into 
three homologous domains (I, H & IH) comprising of residues 1-190, 191-382 and 383-
•'!f?!^^^'?^-f'^'^^F - i ^ ^ ^ ^ ^ r y y •''^i^ 4''Ept-?w^"^vJvvfi^fi'»(Sf'S'^ -^  ^ ^^'%'-iP,^s-~*'^ tr siff^ **n^^^;^j^:q;SiCB4'%•s& ,^^ fSs^S3fi?t^^ 
Figure 1. Illustration of the primary structure of human serum albumin 
(Adapted from Peters, 1985) 
585 in the primary sequence of albumin (Brown, 1977). The sequence homology 
between these domains is 18-25% (Brown, 1977). The charge distribution of HSA at 
neutral pH for domains 1, II and III are -9, -8 and +2 respectively (Peters, 1985). From the 
observations of loops and other homologies. Brown (1977) and McLachlan & Walker 
(1977) deduced that albumin has evolved from smaller proteins, one third or even one 
ninth of the present size by gene fusion. 
X-ray Strwc^ture-The three dimensional structure of HSA has been deteimined by X-ray 
o o 
crystallography at a resolution of 2.8 A by He & Carter (1992) and more recently at 2.5A 
resolution by Sugio and his group (Sugio et al, 1999). Each of the three homologous 
domains (1, II «& III) of albumin is further divided into two subdomains 'A' and 'B' 
respectively and these domains are arranged in such a way to give rise a heart shaped 
o 
molecule (Figure 2) that can be approximated to an equilateral triangle with sides of 80 A 
o 
and depth of-30 A (He & Carter, 1992). The subdomains are extensively cross-linked by 
disulfide bridges which form the basis of the occurrence of 9 loops (3 in each domain) in 
albumin molecule. Albumin structure is predominantly a-helical (Jacobsen, 1972; 
Sjoholm & Ljungstedt, 1973; Chen & Lord, 1976; McLachlan & Walker, 1977). There 
are 10 principal helices in each domain, hl-h6 for subdomain 'A' and h7-hl0 for 
subdomain 'B'. Further, the six subdomains share a common helical motif which 
corresponds to the amino acids encompassed within the double disulfide loops 1,3,4,6,7 
tVis^i;Ma«f^Mi?<k>3A^/?''«l»J*-d'i*-«i^> i^r*->tf^* A <• ^-^^ ^•'•^1-^ ^y t v.-* 
Figure 2. Stereo view of the heart shaped structure of human serum 
albumin with overall topology and secondary structure (Adapted from 
Carter & Ho, 1994) 
and 9 wherein each motif is related by a pseudo twofold axis (1:168°, 11:163°, 111:171°) 
(Carter & Ho, 1994). Distinct differences between subdomains 'A' and 'B' also exist. The 
'A' subdomains supplement the three-helix bundle on the C-terminal side with an 
additional but smaller disulfide double loop (loops 2, 5, and 8) to form a small globin-like 
fold that is extensively cross-linked by four disulfide bridges. The 'B' subdomains 
supplement the helical motif on the N-terminal side with a conformationaUy extended 
polypeptide to create a folding topology that closely resembles a simple up-down helical 
bundle, subdomains 'A' and 'B' assemble through hydrophobic helix packing interactions 
primarily involving h2, h3 and h8. Additionally, the subdomains are linked together by a 
presumed flexible extension of polypeptide encompassing residues Lysio6—dung, 
Glu292—Valsis and CJ3U492—^Alasii in the domains I, II and III respectively. Domains I-II 
and n-in in turn are connected through extensions of hlO(I) - hl(II) and hlO(n) - hl(ni) 
respectively creating the two longest helices in HSA. The actual number of helices in HSA 
is therefore 28 rather than 30 (Carter & Ho, 1994). 
Physico-chemical properties of HSA and BSA are summarized in Table 2. The molecular 
weight of albumins is less than that of most of the other plasma proteins and ranges in 
between 66,000 and 67,000 (Loo et al., 1991). Under neutral conditions of pH, albumin 
has an axial ratio of approximately 2.66 based on the X-ray crystallographic data which is 
in agreement with the value of 3.0 obtained fi"om the studies of dielectric and 
10 
Table 2 
Physico- chemical properties of human and bovine serum albumins 
Properties 
Molecular weight 
Sedimentation constant, S20, wX 10^ ^ 
n 
Diffusion constant, Z)2o, w xlO 
Partial specific volume, V20 
Intrinsic viscosity, rj 
Frictional ratio, f/fa 
Overall dimensions, A 
Isoelectric point 
Optical absorbance, A'^^^' at 279nm 
Mean residue rotation, [^ 3233 
Estimated 
a-helix, % 
P -structure, % 
Human 
66,248" 
4.6" 
6.1'' 
0.733" 
0.042" 
1.28" 
38x150" 
4.7" 
0.531^ 
8590'' 
65™ 
15" 
Bovine 
66,210'' 
4.5'= 
5.9'' 
0.733' 
0.0413^ 
1.30^ 
40x140' 
4.7' 
0.667^ 
8443' 
54" 
18" 
"Peters (1985), "Oncley et al (1947), 'Squire et al. (1968), "Wagner & Scheraga (1956), 
'Hunter (1966), l oeb & Scheraga (1956), ^Creeth (1952), "hughes (1954), tongsworth & 
Jacobsen (1949)^ -'Cohn 1 etal.(l947), ^ Wallevik (1973), 'Moore & Foster (1968), "Dockale^ 
a/. (2000), "Sogami & Foster (1968), "Sjoholm &Ljungstedt (1973), ^eed etal. (1975). 
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birefringence relation times (Moser et al, 1966). The solvent-accessible surface and 
molecular volume of HSA are 28,202 A^ and 88,249 A^ respectively, calculated using the 
molecular coordinates and the algorithm of Richards (1985). The radius of gyration of 
o ^ o 
HSA (26.7A) is similar to the value (26.4A) of hydrodynamic radius of HSA (rotational) 
measured by light scattering and electron spin resonance (ESR) (Cannistraro & Sacchetti, 
1986). HydrodynamicaUy, HSA shows a sedimentation coefficient, S°20, wOf 4.5 x 10 '^ ^ S, 
dififiision coefficient, D%,w of 6.0 x 10 ' cm Vsec (Oncley et al, 1947) and partial 
specific volume of 0.73 3 cc/g (Charlwood, 1961). The intrinsic viscosity of the protein has 
been measured as 4.2 cc/g (Charlwood, 1961). Defatted albumin has an isoelectric point 
of-5.3 whereas a value of -4.7 has been found witii fatted HSA. At physiological pH, 
the calculated net charge is 15 (Peters, 1985). High charge on the protein molecule is 
responsible for its high solubility in water and a solution as concentrated as 30% (w/v) can 
be prepared (Peters, 1985). The specific absorption coefficient, E ' °icm at 279 nm has 
been found to be 5.31 and 6.67 for HSA and BSA respectively (Edwards et al, 1969; 
Janatovae^a/., 1968; Peters, 1985). 
Luetscher in 1939 first showed major reversible conformational isomerization of albumin 
with changes in pH (Luetscher, 1939). Foster studied these earlier observations in much 
greater detail (Foster, 1960; 1977) and classified the pH dependent forms as 'N', for 
12 
normal form, which is predominant at neutral pH; 'B', for basic form occurring above pH 
8.0; 'F', for fast migrating form at pH values less than 4.0; 'E', for expanded form at pH 
less than 3.5 and 'A', for aged form existing with time atpH values greater than 8.0. Most 
of these isomerizations have been studied with BSA, but tbey apparently occur in a similar 
fashion with HSA. 
The 'F' form was recognized by Foster in 1957 who demonstrated that the abrupt 
. discontinuity in the titration of BSA with HCl where about 40 carboxyl side chains 
become titrable (Tanford, 1952) at pH 4.0-4.5 coincided with the appearance of a. faster 
migrating form or 'F' form, as seen on gel electrophoresis at pH 3.0-4.0 (Aoki & 
Foster, 1957). Hydrodynamic properties such as sedimentation rate, diffusion constant and 
intrinsic viscosity show that the 'F' form is longer and increasingly asymmetrical 
(Carter & Ho, 1994). The 'F' form is characterized by a small (6-7%) decrease in the 
a-helical content and a significant (-40%) increase in p-sheet structure (Dockal et al., 
2000). Ultrasonic absorption and velocity spectra (Choi et al., 1990) exhibited a 
relaxation frequency near 200 KHz attributed to the expansion of the molecule. In 
addition to the availability of 40 carboxyl groups to titration, 3 to 5 tyrosyl side chains 
become unmasked (Herskovits & Laskowski, 1962; Steinhardt et al, 1971). There is a 
loss of about 12 binding sites for SDS (Foster, 1960) and a 40-50% increase in ANS 
binding (Foster, 1960). 
At pH values below 3.5, a further unfolding occurs until about pH 2.5, leading the 
13 
molecule to an expanded form constrained by its disulfide bonds. This was termed as 'E', 
or expandedform by Foster (Foster, 1960). Acid expansion is fully reversible. At pH 1.7, 
the intrinsic viscosity increases markedly indicating a change in molecular size as axial 
ratio also increases from 4.0 to 9.0 (Harrington et al., 1956). The molecule appears like a 
chain of globules about 21 x 250A in size as seen under electron microscope (Slayter, 
1965). The helical content decreases from 45% to 35% (Peters, 1985). 
At pH 9.0, albumin undergoes another conformational change to a basic 'B' form Based 
on UV difference spectral results at 287 nm, albiraiin shows increased exposure of some 
tyrosine residues (Williams & Foster, 1959) in the pH range 7.0 to 9.0. Tryptophan 
fluorescence and rotatory relaxation time exhibit little change (Peters, 1996). Small 
reduction (10%) in a-helical content and gain (8%) in P-structure has been foimd using 
CD data (Era et al, 1990). The fluorescent dye ANS shows a decrease in rotatory 
relaxation time from 131 to 114 nanoseconds (Era et al, 1990). 
'A' form or aged form is formed when the albumin is left at pH 9.0 for 3-4 days in salt 
free solution (Sogami et al, 1969). The 'A' form is characterized by a slower 
electrophoresis migration rate and by decreased solubility in 3 M KCl (Nikkei & Foster, 
1971). It has been shown to be the result of a sulfhydryl catalyzed disulfide interchange 
reaction (Era et al, 1990). Blocking of the thiol group with iodoacetamide prevents the 
formation of 'A' form as seen under electron microscope (Slayter, 1965). The helical 
content decreases &om 45% to 35% (Peters, 1985). 
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The denaturation of serum albumin is reversible (Wallevik, 1973; Aoki et al, 1974; 
Reisler et al, 1977) as indicated by the capacity of refolded protein to bind specific 
antibodies, bilirubin and palmitate (Teale & Benjamin, 1977; Wichman et al, 1977; 
Chavez & Benjamio, 1978; Johanson et al, 1981). Albumin can withstand in 8 M urea or 
6 M GdnHCl even at 44*^ C with temporary loss of a-helix without any obvious harm 
(Tanford, 1968). However, prolonged or repeated heating or exposure to alkali causes 
dimerization, imfolding and eventual aggregation. Polymerization and loss of helix occurs 
in less than 1 minute when the protein is exposed to 65 °C at pH 9.0 (Aoki et al, 1973). 
Fatty acid free albimiin tends to aggregate more promptly than fatted albumin (Brandt & 
Andersson, 1976; Shrakee^a/., 1984). A loss of a-helix (from 61% to 44%) and a gain 
of P-structure (from 6% to 16%) occur between 62°C and 75°C as judged by CD, infrared 
and laser Raman studies. The availability of S-S bonds increases from 5% at 60 "C to 
47% at 100 °C (Peters, 1996). The protein is sensitive to the time of exposure at high 
temperature. Effects of heat up to 45°C (Takeda et al, 1989) or to 20% of maximal 
denaturation (Wetzel et al, 1980) are frilly reversible whereas 60% reversibility is found 
after exposure to SO C^. Little changes occur m albumin molecule below 4 M xirea 
concentration (Khan et al, 1987) or 1.8 M GdnHCl (Wallevik, 1973; Katz et al, 1973; 
Aoki et al, 1974) followed by stepwise changes up to about 8 M urea which include a 
rapid initial change followed by molecular expansion (Chmelik et al, 1988). Urea-
15 
induced denaturation of defatted albumin proceeds via an intermediate formation where 
major conformational changes occur in domain in (Khan ei al. 1987; Muzammil et al, 
2000). 
Albumin performs many vital fimctions in the body while circulating in blood plasma. It 
is mainly responsible for the maintenance of blood pH and contributes -80% to the 
coUoid osmotic blood pressure. It is the chief reservoir and carrier for long chain fatty 
acids (Brodersen et al, 1991; Cistola & Small, 1991), their acyl Coenzyme A esters 
(Richards e^  a/., 1990) and mono-acyl phospholipids (Robinson e^  a/., 1989). It binds to 
polyunsaturated fatty acids (Anel et al., 1989) and influences the stability (Haeggstrom et 
al., 1983), biosynthesis (Heinsohn et al., 1987) and conversion of prostaglandins (Dieter 
et al., 1990). It is involved in the transport of thyroid hormones (Mendel et al., 1990) and 
tryptophan (Herve et al., 1982) through reversible binding. It modulates the calciiun ion 
stimulation of gluconeogenesis. It is also involved in the transport of pyridoxal phosphate 
(Fonda et al, 1991), cysteine and glutathione (Joshi et al., 1987) by forming a covalent 
linkage with these ligands. It hydrolyses substituted aspirins (Kurono et al., 1984), 
nitrophenyl esters (Kurono et al., 1979) and guanidinobenzoates (Ohta et al., 1988). The 
tight binding of bilirubin to albumin (Knudsen et al, 1986) prevents the passage of this 
. neurotoxic pigment into the central nervous system in newborns (Esbjomer, 1991) and 
helps in its delivery to the liver for conjugation and excretion . Albumin is responsible 
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for the transport and storehousing of many therapeutic drugs in the blood stream (Lindup, 
1987). Albumin microspheres are useful carriers of therapeutic agents (Morimoto & 
Fujimoto, 1985). Serum albumin is also used in peritoneal dialysis, in combating the 
harmful effect of antibiotics and as scavenger of toxic substances and free radicals (Holt 
et al., 1984). Albumin is an important constituent of tissue culture media (Barnes & Sato, 
1980). It serves as a medium to support growth of microorganisms e.g. bacteria, fungi 
and yeasts (Callister et al., 1990; Morrill et al, 1990). It has been used as replacement of 
blood and plasma for the growth of malarial parasites (Nayar et al., 1991). Albumin acts 
as a carrier for chemotactic factors and affects phagocytosis by leucocytes and 
macrophages (Echarti & Maurer, 1989). It interacts with cell membrane receptors and thus 
enhances the intercellular adhesion of the neuroretinal cells. Albumin is also a carrier for 
haptens. DNP-HSA is often used to test the responsiveness of allergenic systems, such as 
release of histamine from mast cells (Levi-Schaffer et al, 1990). It has also been used in 
preservation of tissues such as human kidney and rat liver (Hatzinger & Stevens, 1989; 
Hellmann et al., 1990). Existence of the condition of 'analbimiinemia' though rare but 
has been observed in many individuals. Clinical manifestation of 'analbuminemia' 
includes chronic fatigue, hyperlipidemia and in rats an increased susceptibility to cancer 
(Kakizoe & Sugimura, 1988). 
Albimiin binds to a wide variety of ligands both exogenous as well as endogenous in 
17 
nature which include metal ions, drugs, fatty acids, bilirubin, anesthetics and peptide 
hormones etc. (Carter & Ho, 1994). Figure 2 illustrate the binding site of various ligands 
on HS A as proposed by Carter and Ho (1994). Most ligands are boimd reversibly with an 
association constant ranging between 10"* to 10^  M'' (Carter & Ho, 1994). Binding sites 
have been primarily studied by equilibrium dialysis or spectroscopic method and the data 
are generally analyzed by Scatchard method (Scatchard, 1949). Some of the important 
informations regarding these binding sites have been gained from the recently determined 
crystal structure of HSA (He & Carter, 1992; Sugio et al, 1999). The two strong binding 
sites reside in subdomains DA and IDA corresponding to Site I and Site n respectively 
as proposed by Sudlow and his group (Sudlow et al, 1976). Although vast majority of 
ligands bind to both sites but subdomain DIA (Site H) seems to possess the primary 
binding activity for albumin whereas subdomain HA (Site I) is more specialized (Carter & 
Ho, 1994). The charge distribution is quite similar for both DA and DIA binding pockets 
but these sites still impart specialized selectivity, hi both the subdomains, there is an 
asymmetric charge distribution leading to a hydrophobic surface on one side and basic or 
positively charged surface on the other (Carter & Ho, 1994). Site H (subdomain DIA) 
shows preference for small aromatic carboxylic acids whereas Site I (subdomain DA) is 
primarily the locus for heterocyclic compounds having negative charge. This is evident 
from the observations suggesting an unusually high reactivity of Lys-199 which can 
be acetylated by aspirin (Walker, 1976) and considered to be the major site of conjugation 
to benzopenicillin groups (Yvon & Wal, 1988) and also appears to be the site for non-
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enzymatic glycosylation (Day etal, 1979). Additionally, Lys-240andLys-238(SiteI 
in subdomain HA) of HSA and BSA respectively have been shown to be important in 
forming a salt bridge with carboxyl group of bilirubin (Jacobsen, 1978) and these 
lysine residues are supposed to be buried in the protein interior (Tayyab & Qasim, 1987; 
Mir et al, 1992). Much of the chemistry of ligand binding to albumin has been gained 
from the observations on the binding of 2,3,5-triiodobenzoic acid which has a moderate 
and equal affinity for subdomains HA and IDA but with distinct geometry (Carter & Ho, 
1994). The absence of a similar bindmig cavity in subdomain lA is interesting which 
has been explained from the crystal structure of HSA. A non-helical section of 
polypeptide allows helix -3 to markedly increase its packing angle with helix-4 and 
thereby effectively eliminating any binding pocket with subdomain lA (Carter & Ho, 
1994). 
Metals primarily bind to the N-terminal region of albvunin (Figure 2) which has high 
affinity for Cu (H), Ni (II), Hg (H), Au (I) and Ag (H). Albumin has weaker affinity for 
calciimi and zinc (Carter & Ho, 1994). Histidine at position 3 is involved in high affinity 
binding ofCu(II)andNi(II). Cys-34 also binds to a number of metals including Au,Ag, 
Hg, Cd and to a lesser extent Cu. The Cys-34 is conserved in mammalian serum 
albimiins. 
Albimiin binds a variety of saturated and imsaturated fatty acids and the number of 
boimd fatty acids depends on the chain length. An average of six fatty acids can bind to 
one albumin molecule (Carter & Ho, 1994) but under normal conditions, albumin carries 
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one or two fatty acids (Peters, 1985). Hamilton et al. (1991) suggested that one primary 
fatty acid binding site exists in subdomain IB (Figure 3) and two additional binding sites 
in domain III which is in agreement with the fact that major sites reside in domains I and 
in of albumin (Peters, 1985), possibly in B subdomains (Brown & Shockley, 1982). 
Binding of fatty acids leads to significant conformational changes in albmnin which 
produces slight opening of the interface between the two halves of the molecule and a 
rotation of domain I (Carter & Ho, 1994) leading to more exposure of environment 
around Cys-34 to the solvent which agrees well with the increased oxidation of Cys-
34 as a function of fatty acids' binding (Takabayashi et al, 1983). 
An enormous number of synthetic drugs bind to albimiin (Figure 2) which caries 
them to the liver where they are degraded and excreted out. Drug-induced displacement of 
bound bilirubin from albumin has prompted an intensive research in the area of drug 
protein interaction because of its relationship to kemicterus in newborn infants 
(Brodersen, 1974; Karp, 1979; Brodersen & Ebbesen, 1983; Brodersen & Robertson, 
1989; Robertson era/., 1991). A large number of drugs, if given to infants may displace 
bUimbin from albumin leading to increased bilirubin concentration in blood whereby the 
imbound pigment may enter the brain causing bilirubin encephalopathy or kemicterus and 
other late stage brain damage (Brodersen, 1974; Robertson et al, 1988; Fink et al, 
1987). Sulfonamide is one major class of drugs which has been shown to displace 
firmly bound bilirubin both /« v/Yro and m v/vo ( Schutta& Johnson, 1971; Bratlid, 
1976) and increases the risk bilirubin encephalopathy/kemicterus. The other class of 
r 
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Figure 3. A model of albumin molecule showing six half-domains 
which are combined to form two sites for binding of bilirubin and 
one for fatty acids (Taken from Brodersen,1979). According to the new 
nomenclature, half-domains AB and C now refer to subdomains A and 
B respectively (Carter & Ho, 1994). 
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drugs which displace firmly bound bilirubin from albumin leading to increased risk of 
bilirubin encephalopathy include, hypnotics and sedatives, drugs used in psychiatric 
disorder, in Parkinson's disease, narcotics, analgesic-antipyretic and anti-inflammatoiy, 
antihistamines, drugs used in chemotherapy of leprosy, tuberculosis and hypoglycemia 
and various antibiotics etc. (Brodersen, 1979). 
Bilirubin is a red bile pigment produced by the catabolism primarily of hemoglobin in 
mammals (Schmid & McDonagh, 1975). Approximately 3-4mg bilirubin / kg of body 
weight is produced per day in healthy adults. In infants, production of bilirubin is high (6-
8mg/ kg) because of greater red blood cell mass and shorter red blood cell life span 
(Gourley, 1997). Increased bilirubin production may lead to the development of 
hyperbilirubinemia as observed in case of neonatal jaimdice (Gourley, 1997). The toxic 
effects of bilirubin are checked by albumin which binds bilirubin and carries it to the 
liver for conjugation with glucuronic acid and subsequent excretion in the form of bile 
from the body and therefore acts as a biologic buffer against bilirubin encephalopathy 
(Brodersen, 1974; 1979; McDonagh &Lightner, 1985). Excess free or unbound bilirubin 
in blood is toxic to various cells and tissues including brain (Brodersen, 1979). The 
condition is more severe in case of himian infants due to increase risk of bilirubin entry 
into the brain because of immature blood brain barrier (Hansen & Bratlid, 1986). Clinical 
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evidences suggest that there may be two kind of bilirubin effects on brain. When many 
infants appear to suffer transiently such as lethargy, anorexia and changes in evoked 
potential, the syndrome is called as bilirubin encephalopathy (Hansen & Bratlid, 1986). 
However, when the result is death or permanent neurological sequelae, the term 
kemicterus (yellow staining of basal ganglia) is commonly used (Schmorl, 1904). 
hicreased entry of bilirubin into brain is associated with reduced bilirubin binding 
capacity of albumin as that of neonatal albumin, hypoalbuminemia, presence of 
displacing agents and opening of blood brain barrier due to hyperosmolality, 
hypercarbia and asphyxia. Recently in experimental animals, it has been observed that 
albumin-bound bilirubin may also enter the brain and thereby further aggravate the risk of 
bilirubin encephalopathy which may be further facilitated by slight opening of blood 
brain barrier (Hansen & Bratlid, 1986; Hansen ef a/., 1987; 1989). 
The effects of bilirubin on neurophysiologic processes have only been studied to a 
limited extent. It has been observed that in the cells, bilirubin is boimd to enzyme 
carrying membranes such as those of mitochondria (Brodersen, 1979). It shows wide 
spread effects on protein phosphorylation by inhibiting various enzymes, namely, cAMP-
, cGMP-, Ca^-cahnodulin- and Ca^^-phospholipid-dependent protein kinases (Hansen e^  
al, 1996). It also inhibits phosphorylation of histones in the brain of 3-4 days old 
rabbit (Morphis et al, 1982). Inhibitory effects of bilirubin on in vivo incorporation of 
leucine into protein in adult Gunn rat brain have also been reported (Greenfield & 
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Majumdar, 1974). 
Bilirubin is a bichromophoric tetrapyrrole (Figure 4A) with several groups capable of 
forming hydrogen bonds, namely two carboxyl, two pyrrole NH, two lactam NH and two 
lactam carbonyls (Bonnett et al, 1978). There are also several hydrophobic groups viz. 
four methyls, two vinyls, two ethylenes and one central (-^ *'CH2-) methylene group. 
The two halves of the parent molecule (each half consists of two pyrrole groups called as 
dipyrrole / pyrromethanone unit) which exist in (Z,Z) configuration (Figure 4A) can be 
rotated a t - C-carbon atom to produce a wide variety of rather different and distinctive 
conformational structures. Upon eiqposure to light, bilirubin is transformed into 
different photoisomers such as E,Z- or Z,E- bilirubin due to rotation of either of the end 
pyrrole ring (Figure 4C) and into E,Z- or £',£'-cyclobilirubins upon prolonged 
photoirradiation due to endo-vinyl cyclization (Brodersen, 1979; McDonagh et al, 
1982a; 1982b; 1989; Lamola et a/., 1983). The photobilirubins are water soluble 
compounds unlike parent bilirubin molecule which is poorly soluble in aqueous solvents. 
Insolubility of bilirubin in aqueous solvents can be ascribed to the tendency to form 
intramolecular hydrogen bonds (Figure 4B) thereby rendering two of its carboxyl groups 
inaccessible to the solvents (Bonnett et al, 1978). The solubility of bilirubin increases 
with the increase in pH of the solution or increase in solvent polarity being higher in 
dimethyl sulfoxide and chloroform (Brodersen, 1979). 
>^Ha CHj 
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Figure 4. Bilirubin IX-a as (A) dianion and (B) acid, intramolecularly 
hydrogen bonded, (C) Photoisomerization of parent compound leads to 
the fonnation of E,Z- or Z.iT-bilirubins and possibly E,Z- or EE-
cyclobilirubins (Adapted from Brodersen, 1979). 
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Albumin has one strong (primary site) and one weak bilirubin binding site (Figure 3) but 
only primary binding site is of physiological importance because of the safe delivery of 
the bound pigment to the liver (Peters, 1992). Affmity labeling as well as studies of 
bilirubin binding to proteolytic fragments and to albumin derivatives suggest that high 
affinity bilirubin binding site resides near loop 4 of subdomain HA (Figure 3) 
encompassing amino acid residues 186-248 (Jacobsen, 1972; 1976; 1978; Reed et al, 
1975; Kuenzle et. al, 1976). These results are in agreement with the observations 
suggesting that in HSA, first bilirubin molecule binds near tryptophan residue at a 
o 
distance of -27 A (Berde et al.,\919) as shown in Figure 5. The second relatively 
weaker binding site resides in domain EI as shown in Figure 3. Bilirubin at the primary 
site binds in a highly specific way in the form of dianion (Figure 4A). It has been 
suggested that the two dipyrrole chromophores of the bilirubin molecule bind to two 
different mobile parts (half domains) of albumin (Figure 3) such that the chromophores 
can be rotated relative to each other upon binding of bilirubin to albumin (Jacobsen & 
Brodersen, 1983). JCinetic studies have revealed that the binding is rapid followed by 
several relaxation steps of conformational changes as seen in the light absorption spectra 
of bilirubin upon binding to albumin (Jacobsen & Brodersen, 1983). 
Although the binding of bilirubin to albumin has been studied for nearly 25 years 
using circular dichroism (CD), nuclear magnetic resonance (NMR) and absorption 
spectroscopy (Harmatz & Blauer, 1975; Kaplan & Navon, 1981; 1982; 1983; Lightiier et 
* rt, •?v^.'^^-if "^, fe 
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Figure 5. A model of human serum albumin showing the position of 
bound bilirubin in the crevasse between domains I & 11 and its average 
distance from the lone tryptophan-214 (Taken from Berde et a/., 1979). 
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al, 1986; 1988), but the conformation of bound bilirubin and nature of binding site on 
albumin remains poorly understood. It is thought that bilirubin binds to albumin in a 
folded dissymmetric conformation (Figure 6) akin to that observed in crystalline bilirubin 
(Nogales & Lightner, 1995). Bilirubin in solution exists in two enantiomeric 
conformations A and B (Figure 6) which are in dynamic equilibriimi A ^ B (Manitto & 
Monti, 1976; Kaplan & Navon, 1983). This equilibrium process is accompanied by 
breaking and remaking all of the six possible intramolecular hydrogen bonds. Albumin 
binds exclusively to one of the enantiomers depending on tiie species chosen and 
induces circular dichroism (CD) in the visible region, in the bound bilirubin. The 
induced CD spectra may be characterized by bisignate CD Cotton effects (CDCEs) or 
monosignate CDCE usually of longer wavelength and negative sign (Harmatz&Blauer, 
1975). In case of bilirubin complexed with HSA, CD spectra is characterized by the 
bisignate CDCEs having minima (-) at shorter wavelength and maxima (+) at longer 
wavelength (Harmatz & Blauer, 1975; Blauer et al, 1977; Lightner et al., 1986; 1988). 
The observed bisignate CDCEs are due to chromophore - chromophore interaction of the 
two locally excited states of the twin pyrrometiianone chromophores i.e. exciton splitting 
(Harada & Nakanishi, 1983). This exciton splitting is especially dependent on the 
magnitude and directions of the two electric transition moments / electric dipole moments 
involved (Hansen & Boumati, 1980; Harada & Nakanishi, 1983) as shown in Figure 6. 
The sign order in a bisignate CD spectrum depends on the relative helical orientation of 
the two pyrromethanone electric dipole moments. A right handed helicity (positive (P) 
»-^JA V ^ "^ ""^  F^t ss^ -i'js" i-^^v-'^--«^ •\rf v#-^» 1 ^i-»js / ~ v ^w<. '^^n'•^^myx <* 
Figure 6. The two ridge-tile conformational enantiomers of bilirubin.The 
double-headed arrows passing through the dipyrrinone chromophores 
indicate the orientation of electronic transition dipoles of each 
dipyrrinone. Insets show the relative helicities (M, minus or P, plus) 
of the dipoles (Boiadjiev & Lightner, 1997). 
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chiraJity) of the transition moments generates a (+) longer wavelength Cotton effect 
followed by a (-) shorter wavelength Cotton effect as observed in case of bilirubin-HSA 
complex. On the other hand, left handed helical orientation (negative (M) chirality) of 
the electric dipole moments produces inverted CDCEs (Harada & Nakanishi, 1983) as 
observed in case of bilirubin-BSA complex (Harmatz & Baluer, 1975). 
Bilirubin-albumin binding is facilitated by several noncovalent forces such as hydrogen 
bonds, salt linkages, TI-TI van der Waals attractions and generalized hydrophobic 
interactions (Jacobsen, 1977; Brodersen, 1979; 1986). Although, combination and 
topography of these binding elements dictate the three dimensional shape and chirality of 
the bound pigment (Lightnere^ a/., 1986; 1988) but salt linkages (-C00 " ^H3N-)and 
associated intermolecular hydrogen bonds (Figure 7) appear to be of particular 
significance in the pigment binding, orientation and enantioselectivity rather than binding 
alone (Lightner et al., 1986; 1988). In different serum albimiins, there exist variations in 
the combination and topography and to some extent the contribution of these binding 
elements at the pigment binding site as reflected from the differences in the CD spectra of 
their complexes with bilirubin (Harmatz & Blauer, 1975; Khan et al., 2000). According 
toBlauer«&Wagniere(1975), the two chromophores of bilirubin in the complex with 
albumin are fixed at a dihedral angle (Figure 6) formed by rotation around central 
carbon -'*^CH2- atom (Blauer & Wagniere, 1975; Jacobsen & Brodersen, 1983). 
Differences in the CD spectra of bilirubin bound to different serum albumins reflect the 
differences in the dihedral angle between the two pyrromethanone units (Harmatz & 
H H 
Figure 7. Mono-amine salt complexes of intramolecularly hydrogen 
bonded enantiomers of bilirubin. Figure also shows associated 
intermolecular hydrogen bondings from the primary ammonium ion of 
the amino groups possibly of lysine residues in the case of serum 
albumin-bilirubin interaction (Taken from Lightner et al., 1988). 
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Blauer, 1975). 
From a brief review of literature presented above, it is clear that although nature has 
manifested a high degree of sequence homology, similar domain and subdomains 
organization in different serum albumins but an extensive in vitro studies revealed subtle 
differences in bilirubin binding to these serum albumins with respect to both 
conformation and affinity of the pigment (Harmatz& Blauer, 1975; Robertson e/a/., 
1990). Moreover, both in vitro and in vivo studies of phototherapy also showed species 
dependent differences in the photoproducts formation(McDonaghe^a/., 1982a; 1982b; 
Omshi etal., 1986). Among various forces involved in bilirubin-albumin interaction, salt 
linkages existing between carboxyl groups of bilirubin and 8-NH2 groups of lysine 
residues of albumin predominate and these lysine residues are believed to be buried in the 
protein interior having altered pK values (Tayyab & Qasim, 1987; Mir et al, 1992). 
Although, the role ofintemal lysine residues in bilirubin binding has been studied using 
BSA, a detailed investigation with respect to the affinity and conformation of bilirubin 
bovmd to different serum albumins is lacking. In order to understand the mechanism of 
bilirubin encephalopathy and to develop various preventive measures, selection of an 
animal is futile unless the animal albumin binds bilirubin in the similar manner as human 
albumin binds. In view of this, five different mammalian serum albumins from human 
(HSA), rabbit (RbSA), goat (GSA), sheep (SSA) and buffalo (BuSA) were selected and 
their conformational and bilirubin binding properties including conformational stability of 
albumin-boimd bilirubin were studied after modifying the internal lysine residues with 
acetic anhydride, succinic anhydride and 0-methylisourea. 

IMATIMALS AJm MITMOBS 
Various marker proteins viz. y-globulin (lot 72H9312), catalase (lot 120H7060), 
bovine serum albumin (BSA) (lot 124F0752), ovalbumin (lot 13H7025), ribonuclease 
(lot 123H1133) and myoglobin (lot 55H7015) were purchased from Sigma Chemical 
Company, MO, USA. Different serum albumins, namely, human, sheep, goat, rabbit 
and buffalo serum albumins were isolated from their respective plasma by 
ammonium sulfate fractionation method (Tayyab & Qasim, 1990) and purified to 
homogeneity by Seralose-6B gel chromatography. 
> : „ » L * 
Bilirubin-IXa, ulfra pure was purchased from Gedeon Richter, Hungary and was used 
without fiuther purification. Chloroform (99%), analytical grade, was the product of 
Sisco Research Laboratories, Mumbai, India. 
X Stm$<sx^ ami ^jp^&tma em^^^kati&u 
Citraconic anhydride (lot 910425092) and tri-nitrobenzene sulfonic acid (lot 28999) 
were the products of Pierce Chemical Company, YL, USA. 0-Methylisourea (lot 
33 
85H0142) and guanidine hydrochloride (lot 94H5702) were obtained jfrom Sigma 
Chemical Company, MO, USA. Chemically pure samples of succinic anhydride and 
acetic anhydride were supphed by Sisco Research Laboratories, Mumbai, India. 
Hydroxylamine hydrochloride was obtained from Qualigens Fine Chemicals, Mimibai, 
India. 
Seralose-6B (Batch No. B716063) was purchased from Sisco Research Laboratories, 
Mumbai, India and blue dextran 2000 (type D-5751; lot 62H0796) was supplied by 
Sigma Chemical Company, MO, USA. 
Acrylamide (3x crystaUized) and N, N'-methylenebisacrylamide (3x crystallized) were 
purchased from Sisco Research Laboratories, Mumbai, India. Trizma base (tris 
[hydroxymethyl] aminomethane) (lot 14H5717), glycine (lot 113H12551) and 
coomassie brilliant blue R 250 (type B-7920) were obtained from Sigma Chemical 
Company, MO, USA. Analytical grade samples of ammonivmi persulfate, sucrose, 
glycerol, acetic acid and methanol were procured from Qualigens Fine Chemicals, 
Mumbai, India. N, N, N', N'-tetramethylethylenediamine (TEMED) was the product 
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of Fluka, AG, Switzerland. 2-Mercaptoethaiiol was purchased from E. Merck, 
Darmstadt, Germany. Bromophenol blue was the product of B. D. H., Poole, England. 
Analytical grade samples of sodium carbonate, sodium potassium tartarate, copper 
sulfate, orthophosphoric acid, lithium sulfate, sodium molybdate, sodium tungstate and 
hydrochloric acid were obtained from Qualigens Fine Chemicals, Mvmibai, India. 
Liquid bromine was procured from Sigma Chemical Company, MO, USA. Folin-
phenol reagent was prepared according to the standard procedure (Folin & Ciocalteu, 
1927). Copper reagent was prepared fresh by mixiug 1 volume of 4% (w/v) sodium 
potassiimi tartarate to 100 volumes of 4% (w/v) sodium carbonate and finally adding 1 
volume of 2% (w/v) copper sulfate. 
7.. 
Sodium dihydrogen phosphate, disodium hydrogen phosphate, sodium hydroxide, 
potassium dichromate, potassiimi hydrogen phthalate, sodium tetraborate, potassiimi 
permanganate, sodium azide and ethanol were of analytical grade and obtained from 
QuaUgens Fine Chemicals, Mumbai, India. Dialysis tubing of 1 inch width was 
obtained from Sigma Chemical Company, MO, USA. Millipore filters (pore size 0.45 
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^m) were purchased from MiUipore (India) Pvt. Ltd., Bangalore, India. Whatman 
filter papers (No. 1) were the product of Whatman International Ltd, Maidstone, 
England. Parafilm 'M' was obtained from American Can Company, CT, USA. pH 
indicator papers were supplied by Qualigens Fine Chemicals, Mumbai, India. Solid 
glass beads (5 mm diameter) and glass wool were obtained from S.D. Fine Chemicals, 
Boisar, India. 
All glass distilled water was used throughout these studies. All the experiments were 
performed at room temperature (~ 25 ''C) imless otherwise stated. 
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Iv pMmemmmm«its 
pH measurements were carried out on an Elico digital pH meter, model LI 610 using 
a combined electrode, type CL-51. The least count of the pH meter was 0.01 pH irnit. 
The pH meter was routinely calibrated at room temperature with either 0.05 M 
potassiimi hydrogen phthalate buifer, pH 4.0 in the acidic range or 0.01 M sodium 
tetraborate buffer, pH 9.2 in the alkaline range. 
Protein concentration was determined either spectrophotometrically or by the method 
of Lowry et al. (1951) using BSA as the standard. 
SpeiStiepkfttmmif^ mstko^ — Protein concentration was determined following 
absorbance measurement at 280 nm on a Cecil double beam spectrophotometer, 
model CE 594 and using the value of specific extinction coefficient (E °icm ) as 5.30 
and 6.67 for HSA and BSA respectively (Peters, 1985). 
Melltod eflmm^ et at f]l9$i} - Increasing volumes of stock protein solution (300 
|ag/ml) in the range of 0.1-1.0 ml were taken in different test tubes and the voliune in 
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each tube was made to 1.0 ml, if required, with 0.06 M sodiimi phosphate buffer, pH 
7.0. Then, 5.0 ml of freshly prepared copper reagent was added to all the tubes and the 
contents were mixed well. After 10 minutes of incubation at room temperature, 1.0 ml 
of diluted Folin-phenol reagent was added and vortexed. The tubes were incubated for 
30 minutes at room temperature and the color intensity was read at 700 nm against a 
suitable blank prepared in the same way as that of test solution except that instead of 
protein solution, 1.0 ml of buffer was taken. A calibration curve, thus obtained, 
between absorbance at 700 nm and amount of protein yielded the following straight 
line equation (Figure 8): 
\-3 (Absorbance)7oo nm =" 1.9x10" (amount of protein, |j,g) + 0.04 (1) 
XFehi 
Electrophoresis of various senmi albumins and their modified derivatives was 
performed in 8% (w/v) polyacrylamide gel using 0.02 M tris- glycine buffer, pH 8.2, 
ionic strength 0.02 following the method of Laemmli (1970) under non-denaturing 
conditions. About 5-8 jig of the protein was loaded in 10-20 [il sample buffer and a 
current of 3-4 mA per well was applied for nearly 2 hours. The gel was stained with 
the staining solution containing 0.25% (w/v) coomassie brilliant blue in 40% (v/v) 
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Figure 8. Standard curve for the determination of protein concentration 
by the method of Lowry et al. (1951) using bovine serum albumin as 
the standard. Straight line was drawn by the method of least squares. 
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methanol and 10% (v/v) acetic acid and destained with 10% (v/v) acetic acid solution 
containing 10% (v/v) methanol at 37*^ C. 
Acetylation, succinylation and guanidination of internal lysine residues of different 
serum albumins were carried out according to standard procedures (Riordan & Vallee, 
1967; Klotz, 1967; Kimmel, 1967) using a double modification approach (Mir et al., 
1992). The surface lysine residues (completely as well as partially exposed) of these 
albumins were first protected by using a reversible modifier, citraconic anhydride 
(Dixon & Perham, 1968). For each albumin, the desired concentration of citraconic 
anhydride to covalently block -80% surface lysine residues was obtained by treating 
each albumin separately with increasing anhydride concentrations. The reaction was 
performed in 0.1 M sodium phosphate buffer, pH 8.0 for about 30-40 minutes. The pH 
of the reaction mixture was maintained at pH 8.0 by simultaneous addition of 0.5 N 
NaOH. After completion of the reaction, the preparation was dialysed against 0.06 M 
sodiimi phosphate buffer, pH 8.0 to remove excess modifier. The extent of 
citraconylation was determined by TNBS reaction method (Hebeeb, 1966) and 
percentage modification was calculated using the following straight line equation: 
% modification = ( 1 - m / nio) x 100 (2) 
where m and nio are the slopes of the plots between absorbance at 340 nm and amount 
40 
of protein, obtained with native and modified albumins drawn by the method of least 
squares. Using appropriate concentration of citraconic anhydride, about 80% lysine 
residues of each albumin were modified in the same way as described above. These 
80% citraconylated albumin preparations were imfolded with 6M guanidine 
hydrochloride to expose internal unmodified lysine residues and divided into four 
parts. The three of the four parts of each citraconylated albiraun were then treated with 
acetic anhydride, succinic anhydride and 0-methylisourea respectively to modify 
internal (-20%) lysine residues. The fourth part was kept for testing the reversibility 
and consequences of citraconylation on protein conformation, if any. Acetylation, 
succinylation and guanidination were carried out as described earlier (Riordan & 
Vallee, 1967; Klotz, 1967; Kimmel, 1967). These preparations were then thoroughly 
dialysed against 0.05 M sodium acetate buffer, pH 3.5 at 10°C for 96 hours to remove 
citraconyl groups. The extent of acetylation, succinylation or guanidination was 
determined by TNBS reaction method (Habeeb, 1966). The homogeneity of these 
preparations was checked by PAGE (Laemmli, 1970) as well as Seralose-6B gel 
chromatography (Tayyab et al, 1991). For the quantification of modification, total 
number of amino groups was taken as 60 in both HSA and RbSA and 59 in SSA 
(Peters, 1985; Carter & Ho, 1994; Peters, 1996). Based on the similarities in the 
molecular properties of GSA and BuSA with those of HSA, the total number of amino 
groups in these albumins was also assimied to be 60. The site specificity of different 
modifiers used in this study, towards amino groups has been well documented 
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(Riordan &. Vallee, 1967; Klotz, 1967; Kimmel, 1967). However, modification of 
other residues, if any, was made reversible in all these preparations following standard 
procedures (Gounaris & Ottesen 1965; Riordan & Vallee, 1967b; Freedman et al, 
1968). Therefore, these preparations were assumed to have only internal lysine 
residues modified. 
Analytical gel chromatography was performed in the same way as described earlier 
(Tayyab et al., 1991) using a Seralose-6B colimrn (80 x 1.15cm) equilibrated with 
0.06M sodiimi phosphate buffer, pH 7.4. The column was calibrated by passing, at 
least three times each of the marker proteins, namely, y-globulin, catalase, BSA, 
myoglobin and ribonuclease. The mean values of their elution volumes were 
normalized in terms of distribution coefficient, Kj and available distribution 
coefficient, Kav according to standard procedures (Andrews, 1970). The data were 
analysed as described by Laurent & Killander (1964) and Ackers (1967) which fit the 
following straight line equations (4) and (5) respectively (Figure 9): 
(-log Kav)'''^  = 0.077 (Stokes radius, nm) + 0.15 (3) 
Stokes radius, nm = 9.74 erfc"% + 0.78 (4) 
where erfc" K<j is the inverse error fimction complement of K .^ 
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CD measurements were made on a Jasco spectropolarimeter, model J-720 equipped 
with a microcomputer. The instrument was caUbrated with d-lO-camphorsulfonic 
acid. All the measurements were carried out at 25°C with tibe help of a thermostatically 
controlled cell holder attached to a Neslab's RTE-110 circulating water bath with an 
accuracy of ±0.1° C. Far-UV (200-250 run) CD spectra were taken at a protein 
concentration of 2 ^M with a 1 mm path length cell. Spectra were collected at a scan 
speed of 20 nm / minute and with a response time of 1 second. Each spectrum was the 
average of 4 scans. In the near UV region (250-300 nm), CD spectra were measured at 
a proteia concentration of 20 (iM with a 10 mm path length cell. The results are 
expressed as mean residue ellipticity (MRE) in deg.cm .dmol' which is defined as: 
MRE = 0obs(mdeg)/lOxnxlxCp (5) 
where Gobs is the CD in miUidegree; n is the number of amino acid residues; 1 is the 
path length of the cell and Cp is the mole fraction. The heUcal contents of different 
albvmiins and their derivatives were calculated from the MRE value at 222 nm using 
the following equation as described by Chen etal. (1972): 
% helix = (MRE222—2340 / 30300) xlOO (6) 
The visible range CD spectra were measured in the wavelength range of 350-550 nm at 
44 
25 ± 0.1° C using a cell holder of 10 mm path length. The spectra were collected at a 
scan speed of 500 nm / minute with a response time of 1 second. Each spectrum was 
the average of 3 scans. 
Fluorescence measurements were carried out on a Shimadzu spectrofluorometer, 
model RF-540 equipped with a data recorder, DR-3 at 25 ± 0.1° C. The fluorescence 
was recorded in the wavelength range 300-400 nm after exciting the protein solution 
either at 295 nm exclusively for tryptophan fluorescence or at 280 mn for total protein 
fluorescence. Induced fluorescence of albumin-bound bilirubin was recorded ia the 
wavelength range 480-580 nm after exciting the samples at the maximum wavelength 
of their respective absorption spectra (Chen, 1974). The sUts were set at 3 and 5 nm 
for excitation and emission respectively. The path length of the sample cuvette was 
1 cm. 
Binding of bilirubin to native and modified albumins was studied using fluorescence, 
CD and absorption spectroscopy. Bilirubin binding experiments were performed in 
0.06 M sodium phosphate buffer, pH 8.0, ionic strength 0.15. Bilirubin solution was 
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prepared by dissolving ~5 mg solid bilirubin crystals in 1 ml of 5 mM NaOH solution 
containing ImM EDTA and immediately diluting it with the above buffer. The 
concentration of bilirubin was determined spectrophotometrically using a molar 
absorption coefficient of 47,500 M"' cm"^  at 440 nm (Jacobsen & Weimberg, 1974). 
All the spectral measurements were made after incubating bilirubin-albumin solution at 
least for 30-40 minutes at 25''C. The spectra were recorded in dim / yellow Ught to 
prevent imdesired photodegradation of bilirubin. 
The fluorescence quench titration of native or modified albumin derivatives with 
increasing bilirubin / protein molar ratios was performed in a discontinuous manner. 
To 1 ml of stock protein solution (1-3.5 |JM), increasing volumes of stock bilirubin 
solution (1.2 mM) were added. The total incubation mixture was 3 ml. The molar ratio 
of bilirubin / protein was varied between 0.1 and 1.0. The fluorescence quench 
titiation data were analyzed by fitting them in Scatchard plot (Scatchard, 1949) as 
described by Levine (1977) using the following equation: 
nKa ~ KaQ = Q/[B] = Q/(i?-<2)[albumin]T (7) 
where n is the binding capacity, Ka is the association constant, Q is the fractional 
quench, [B] is the free bilirubin concentration, [albimunjx is the total albumin 
concentration and R is the bilirubin / albumin molar ratio. The value of Ka was 
obtained from the slope of the plot between Ql\&\ Vs Q. 
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The visible range CD spectra of bilirubin-albumin solutions were made at a fixed 
bilirubin (10 ^M) / albumin (20 |j,M) molar ratio of 0.5:1.0. The results are expressed 
as molar eUipticities [Q]x in deg. cm . dmol" which is defined as: 
10 0 
[9], = (8) 
c.d. 
where 0 is the observed eUipticity in degrees; c is the concentration in moles / liter of 
total bilirubin and d is the path length in decimeters. 
Bilirubin bindiQg to albumin was also studied by absorption spectroscopy performed 
either on a CECIL double beam spectrophotometer, model CE 594 or on a Backman 
DU-600 spectrophotometer. The absorption spectra of free bilirubin (10 /iM) as well 
as bound to albimiin (20 |aM) was recorded in the wavelength range 370-550 mn using 
a cell holder of 1cm path length. The results are expressed in terms of molar 
absorption coefficient (e) in M"\cm'* with respect to the total bilirubin present in 
solution. 
The switching of boimd bilirubin from modified albumin derivatives to their native 
forms was studied by CD spectroscopy. In brief the protocol is as follows: first 
bilirubin was incubated with modified derivatives (acetylated as well as succinylated) 
at a bilirubin / albiraiin molar ratio of 0.5:1.0 for 30-40 minutes at room temperature in 
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dark. Then the solution was divided in two parts; in one part required amount of 
native form of the same acetylated or succinylated albumin species was added to get a 
bilirubin / albumin molar ratio of 0.5:1 with respect to native albiunin and in the 
second portion, equal voliune of reaction buffer was added and both the solutions were 
then incubated for 30-40 minutes at 25°C in dark. The CD measurements were carried 
out as described above. To verify the results of competition experiments, same 
protocol was repeated in reverse order i.e. bilirubin was first incubated with native 
albumin followed by the addition of modified derivatives (acetylated or succinylated) 
of the same albumin. 
M ^ei^tefdl^lmpfmm @ii Ift© €© ^ ^dra ^fmHrn^JsMl^tfiMi'^Qiikm^ti mmpimm 
The CD specfra of various bilirubin-albumin complexes equihbrated with chloroform 
were measiu-ed in the same way as described above but either prior to or after the 
addition of bilirubin (10 i^M) to albumin (20 jxM), protein solution was equilibrated 
with ~20 mM chloroform for 1 hour under atmospheric conditions (Pu et al., 1993) and 
the measurements were made after 30-40 minutes incubation of bilirubin-albmnin 
solution at 25°C in dark. 
lis 
For the measurements of photoinduced changes in the fluorescence of bilirubin-HSA 
complex, samples were continuously irradiated in the spectrofluorometer using a 
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Xenon lamp of 150 W and a 10 nm bandwidth interference filter centered either at 440 
or 468 nm and the fluorescence of the bomid bilirubin was simultaneously monitored 
at 530 nm. The light intensity was supposed to be in the range of 40-50 |iW cm' 
(Lamola et al, 1981). The photoinduced alterations in the CD spectrum of bilirubin-
HSA complex were measured afl:er irradiating the sample under white fluorescent 
light generated from a 40 W (FTL) white fluorescent tube. The samples were irradiated 
for varying time periods i.e. 0, 2, 4, 6, 10, 15 and 30 minutes and then successively 
transferred to the dark and the CD spectra were recorded as described above. 
In the present investigation, the effect of white fluorescent light on the CD spectrum 
of bilirubin-HSA complex was found to be most effective as compared to the Ught of a 
particular wavelength (440 or 468 nm). Therefore, most of the photoinduced 
alterations in the CD spectrum were measured after irradiating the samples under white 
fluorescent Ught as described above. 
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Me^Sfkaikm efinternal fyssm^ f&sMmes; 
Usually charged residues in proteins are present at the surface where they interact with 
other charged groups and / or become solvated with aqueous phase in protein hydration 
spheres. Few charged residues are also found in the protein interior where they can 
form electrostatic interactions with the oppositely charged residues (Burley & 
Petsko, 1988). In BSA, approximately 20% of the total lysine residues are buried in 
the protein interior (Jonas & Weber, 1970). Similarly in HSA, some of the lysine 
residues are not reactive to tri-nitrobenzene sulfonic acid (Goldfarb, 1970). Further, 
involvement of biuied lysine residues has been reported in bilirubin-albimiin 
interaction (Tayyab«&; Qasim, 1987;Mire?a/., 1992). These observations led us to 
believe that a few (~ 18-20%) lysine residues in serum albumins are located in an 
imusual environment in the protein interior. In view of this we checked the reactivity 
of lysine residues of different senmi albumins, namely, human, goat, sheep, buffalo 
and rabbit serum albumins towards citraconic anhydride. Figures 10-14A show 
quantification of modification (citraconylation) of lysine residues of different serum 
albumins using TNBS reaction method (Habeeb, 1966) at different molar ratios of 
citraconic anhydride to protein. A progressive increase in citraconylation was 
observed with the increase in citraconic anhydride concentration which sloped off at 
higher anhydride concentration (see insets of Figures 10-14A). A comparison of these 
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results suggests that in all albumins, nearly 80±3% lysine residues are completely 
accessible to the modifier whereas remaining 20±3% are buried to different extent in 
the protein interior and thus require higher anhydride concentration for their 
modification. Based on initial reactivity, BuSA, SSA and RbSA showed differences 
with H S A and GSA and these differences were eliminated at higher degree of 
modification. As can be seen from the insets of Figures 10-14 A, nearly 90-140 molar 
excess of anhydride is required to achieve 80% modification of lysine residues of 
different serum albumins. In order to reversibly block ~80% lysine residues of 
different serum albumins, the required anhydride concentration was selected from the 
curves shown in the insets of Figures iO-14A and these albumins were submitted 
to citraconylation. As desired, the extent of citraconylation in these preparations 
was found to lie near the expected value of ~80% when checked by TNBS reaction 
method (Habeeb, 1966). Remaining -20% buried lysine residues were then modified 
with a ~i 00 molar excess of acetic anhydride, succinic anhydride and 0-methylisourea 
after exposing them with 6M guanidine hydrochloride. These preparations were 
submitted for hydroxylamine treatment (Riordan & Vallee, i967b) and then dialyzed 
against 0.05M sodium acetate buffer, pH 3.5 for 96 hours at 10°C to remove the 
citraconyl groups. Therefore, all these preparations had only internal lysine residues 
modified. The extent of modification of intemal lysine residues in different serum 
albimiins as determined by T N B S reaction method (Figures 10-14B) was foimd to 
be 20±3% (Table .3). ^^ T a^kingit^ e total number of amino groups in these albumins as 
r 
-^> ' ^ > 
( Ace. No 
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Table 3 
Extent of internal lysine residues modification and its influence on tryptophan (trp) 
fluorescence and mean residue ellipticity (MRE) of different serum albumins. 
Albumin 
derivatives 
HSA 
gHSA 
aHSA 
sHSA 
RbSA 
gRbSA 
aRbSA 
sRbSA 
GSA 
gGSA 
aGSA 
sGSA 
SSA 
gSSA 
aSSA 
sSSA 
BuSA 
gBuSA 
aBuSA 
sBuSA 
e -NH2 groups" 
modified 
(%) 
0(0) 
19(11) 
17 (10) 
18(11) 
0 ( 0 ) 
23 (13) 
20 (12) 
22 (13) 
0 ( 0 ) 
19(11) 
21 (13) 
18(11) 
0 ( 0 ) 
23(13) 
20(12) 
22 (13) 
0 ( 0 ) 
23 (13) 
19(11) 
19(11) 
trp fluorescence 
intensity and 
^max (nm) 
100 (340) 
99 (337) 
88(331) 
80 (330) 
100 (343) 
96(341) 
81 (334) 
74 (332) 
100 (342) 
97 (340) 
82(333) 
75 (333) 
100 (342) 
95(341) 
83 (335) 
80 (332) 
100 (342) 
96 (340) 
83 (335) 
77 (331) 
MRE262rm 
(deg. cm^. dmot') 
-124 
-128 
-97 
-88 
-122 
-124 
-92 
-80 
-126 
-127 
-95 
-88 
-126 
-126 
-98 
-89 
-120 
-122 
-108 
-100 
MRE222nm 
(deg. cm^. dmot') 
-20010 
-19980 
-19890 
-19870 
-19620 
-19600 
-19070 
-18640 
-20000 
-19860 
-19850 
-19280 
-20300 
-20068 
-20079 
-20020 
-19873 
-19780 
-19560 
-19550 
"Each value of percent modification represents an average of 2-3 independent observations with a precision of 
3%. Percent modification was calculated by taking total number of amino groups in different serum albumins 
as mentioned in the Materials and Methods section. Number of amino groups modified are given in parentheses. 
"In GSA and BuSA, tiie MRE values were calculated by taking into account the total number of amino acid 
residues as 584. 
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60 or 59 (59 or 58 8-NH2 + 1 a-NHa), the number of lysine residues modified was 
foimd to be 10-13 (see Table 3). This was in good agreement to the value reported 
for BSA (Jonas & Weber, 1970; Mir et al, 1992). Since the same 80% citraconylated 
preparation of various albimiins was modified with three different modifiers after 
dividing it into three parts, it was assiimed that the same set of internal lysine 
residues was modified in these preparations. Modification of 8-NH2 group of lysine 
residues can be viewed as under: 
Lys-
(atphy siological pH) 
Acetylation 
Succinylation 
Guanidination 
Lys-NH-
Lys-NH-
Lys-NH 
0 
II 
C- CH3 
0 
II 
C (CH2)2-
NH2^ 
II 
- C-NH2 
COO 
All these preparations (acetylated, siiccinylated and guanidinated) were foimd to be 
homogeneous with respect to size and charge as they eluted in a single symmetrical 
peak fi-om a Seralose-6B gel filtration column (Figures 15-19) and gave a single band 
on 8% polyacrylamide gel (insets of Figures 15-19). Since acetylation and 
succinylation replace the positive charge on lysine residues with zero charge and a 
negative charge respectively, a slight increase in relative mobility in some of these 
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Figure 15. Elution profile of HSA (O) obtained on a Seralose - 6B column 
(80 X 1.15cm) equilibrated with 0.06 M sodium phosphate buffer, pH 7.4. 
Letters 'A', 'G' and 'S ' indicate the positions of acetylated, guanidinated and 
succinylated HSA derivatives. Inset shows electrophoretic pattern of 
native and modified HSA derivatives on 8 % polyacrylamide gel. Same 
symbols are used for modified derivatives whereas 'N' stands for native HSA. 
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Figure 16. Elution profile of RbSA (O) obtained on a Seralose - 6B column 
(80 X 1.15 cm) equilibrated with 0.06 M sodium phosphate buffer, pH 7.4. 
Letters 'A', 'G' and 'S ' indicate the positions of acetylated, guanidinated and 
succinylated RbSA derivatives. Inset shows electrophoretic pattern of 
native and modified RbSA derivatives on 8 % polyacrylamide gel. Same 
symbols are used for modified derivatives whereas 'N' stands for native RbSA. 
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Figure 17. Elution profile of GSA (O) obtained on a Seralose - 6B column 
(80 X 1.15 cm) equilibrated with 0.06 M sodium phosphate buffer, pH 7.4. 
Letters 'A', 'G' and 'S ' indicate the positions of acetylated, guanidinated and 
succinylated GSA derivatives. Inset shows electrophoretic pattern of 
native and modified GSA derivatives on 8 % polyacrylamide gel. Same 
symbols are used for modified derivatives whereas 'N' stands for native GSA. 
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Figure 18. Elution profile of SSA (O) obtained on a Seralose - 6B column 
(80 X 1.15 cm) equilibrated with 0.06 M sodium phosphate buffer, pH 7.4. 
Letters 'A', 'G' and 'S ' indicate the positions of acetylated, guanidinated and 
succinylated SSA derivatives. Inset shows electrophoretic pattern of 
native and modified SSA derivatives on 8 % polyacrylamide gel. Same 
symbols are used for modified derivatives whereas 'N' stands for native SSA. 
1.2 -
E 
o 0.9 
CO 
M 
* i » 
CO 
a> 
g 0.6 
S 
o 
< 0.3 -
-
M l 
.J 
Q 
% 
1 1 
S AG N 
' 1 
O ' 
6 b 
1 1 
0 6 
1 J 
200 240 280 320 360 
Elution volume (ml) 
400 
Figure 19. Elution profile of BuSA (O) obtained on a Seralose - 6B column 
(80 X 1.15 cm) equilibrated with 0.06 M sodium phosphate buffer, pH 7.4. 
Letters 'A', 'G' and 'S ' indicate the positions of acetylated, guanidinated and 
succinylated BuSA derivatives. Inset shows electrophoretic pattern of 
native and modified BuSA derivatives on 8 % polyacrylamide gel. Same 
symbols are used for modified derivatives whereas 'N' stands for native BuSA. 
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preparations is understandable (insets of Figures 15-19). Guanidinated preparations, 
on the other handj moved with the mobility similar to that of native albumin. 
Figures lO-lAA show far UV^CD spectra of various native and modified albumin 
derivatives obtained at pH 7.4. Spectra were characterized by the presence of two 
minima at 208 and 222 nm, characteristics of a-helical structure (Sjoholm & 
Ljimgstedt, 1973; Dockal et al, 2000)> Acetylation or succinylation of internal 
lysine residues of different serum albumins resulted in a small decrease in the MRE 
value being higher in succinylated preparations compared to acetylated derivatives (see 
Table 3). A maximum decrease of 5% was observed in sRbSA followed by sGSA 
' which showed 3.6% decrease (Table 3). Other sefUni albumin deri^ vatives did not show 
any detectable change in the helical content upon acetylation as well as succinylation 
of internal lysine residues. These results were ui accordance with the earlier reports 
suggesting that the secondary structures are independent and resistant to chemical 
modification (Batrae/a/., 1990). 
Structural changes in the three dihiensional conformation of different serum albumins, 
induced by covalent modification of internal lysine residues were checked by CD 
measurements in the near-UV region. Figures 20-24B show near-UVCD spectra of 
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Figure 20. [A] Far-UV and [B] near-UV CD spectra of HSA (—) and its 
modified derivatives viz. gHSA (—), aHSA (—) and sHSA (-•-). 
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Figure 21. [A] Far-UV and [B] near-UV CD spectra of RbSA (—) and its 
modified derivatives viz. gRbSA (—), aRbSA (- -) and sRbSA (-•-). 
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Figure 22. [A] Far-UV and [B] near-UV CD spectra of GSA (—) and its. 
modified derivatives viz. gGSA (—), aGSA (- -) and sGSA (-•-). 
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Figure 23. [A] Far-UV and [B] near-UV CD spectra of SSA (—) and its 
modified derivatives viz. gSSA (—), aSSA (- - ) and sSSA (-•-). 
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Figure 24. [A] Far-UV and [B] near-UV CD spectra of BuSA (—) and its 
modified derivatives viz. gBuSA (—), aBuSA (—) and sBuSA (-r-). 
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native and modified albumins recorded in the wavelength range of 250-300 run. As 
can be seen from these figures, spectra of native albumins show two minima at 262 
and 268 nm as well as two shoulders around 277 and 285 nm respectively, 
characteristics of aromatic chromophores and disulfide bridges. Near-UVCD spectra 
of different serum albumins were in agreement with earlier observations reported 
for HSA and BSA (Sjoholm & Ljungstedt, 1973; Sjodin et at., 1977; Dockal et al, 
2000). These spectral characteristics in the near-lJVCD spectra though retained by all 
the modified derivatives of different serum albumins, quantitative differences in the 
MRE values were noticed among these derivatives (Table 3). In acetylated as well as 
succinylated albumin derivatives of different serum albiunins, a decrease in the 
ellipticity value both at 262 and 268 nm was noticed whereas above 280 nm, the 
ellipticity value increased slightiy indicating the change in the asymmetry of the 
protein's aromatic amino acids' environment and/or disiilfide bridges (Sogami et al, 
1982; Muzammil et al, 1999; Dockal et al, 2000). A slight increase in the 
ellipticity value between 280 and 300 nm in different acetylated and succinylated 
derivatives can be ascribed to the immobilization of tryptophan side chain in a more 
hydrophobic environment (Dockal et al, 2000) which was in accordance with the blue 
shift in the tryptophan emission maxima (as shown in Figure 25) observed with these 
derivatives. On the other hand, near-UVCD spectra of guanidinated albumin 
derivatives were more or less similar to the one obtained with native albumins. These 
results clearly suggested the importance of positive charge on the intemal lysine 
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residues in maintaining the structural integrity of native protein conformation. Similar 
changes in tihe ellipticity values have also been reported during pH dependent 
conformational transition of HSA and BSA (Sogami et ai, 1982; Muzammil et al, 
1999; Dockai et al, 2000). Therefore, disruption of some intra-molecular salt bridge 
interactions, steric manifestations due to bulkier acetyl and succinyl groups and 
cbafge-cliarge repulsion, all contribute towards flie perturbed tertiary packing in 
acetylated and succinylated albumin derivatives. 
Based on the available amino acid sequence data, nearly all mammalian serum 
albumins contain one or two tryptophan residues located either in domain n or both in 
domains I and 11 respectively (Carter & Ho, 1994). In an earlier study, bilirubin 
binding site in HSA has been suggested to lie in the close vicinity of tryptophan of 
domain H at a distance of 27 A (Sudlow et al, 1976; Berde et al, 1979). Taken 
together, the involvement of buried lysine residue(s) of BSA in bilirubin-albumin 
interaction ( Mir et al, 1992) and the location of bilirubin binding site in the close 
vicinity of tryptophan (Berde et al, 1979) it seems necessary to investigate the 
changes in the microenviromiient around tryptophan residue(s) after the 
modification of buried lysine residues of these albimiins. Changes in the enwonment 
around tryptophan residue(s) can be precisely detected from the fluorescence 
properties of modified albumins by using an excitation wavelength of 295 nm where 
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only tryptophan is excited and contribution from other aromatic chromophores is 
negligible (Schmid, 1997). Figure 25 (A-E) shows tryptophan fluorescence spectra of 
different serum albumins and their modified derivatives. Qualitatively similar 
fluorescence spectra were observed with different serum albimiins and their 
derivatives. However, quantitative differences in the fluorescence intensity and 
emission maxima were noticed (see Table 3). As can be seen from Figure 25 and 
Table 3, both quantum yield and emission maxima affected to an appreciable extent 
by acetylation as well as succinylation of internal lysine residues in all the serum 
albimiins under investigation, whereas guanidination did not affect these parameters to 
a significant extent. Decrease in fluorescence intensity (12-26%) and shift in the 
emission maxima towards shorter wavelength by about 9-11 nm in acetylated and 
succinylated derivatives of all the albumins ^ suggested that few acetyl or succinyl 
groups were incorporated on to those critical lysine residues which seem to be located 
in the close vicinity of tryptophan and thus changed the microenvironment. Since the 
# 
extent of blue shift and decrease in fluorescence intensity observed with HSA 
(containing a lone tryptophan-214 in domain 11) upon acetylation or succinylation 
were more or less similar to those observed with the same derivatives of other 
albumins, it can be said that change in the microenvironment was mainly confined to 
the tryptophan present in domain II in these albumins. These observations suggest 
that some of the internal lysine residues make a significant contribution to the binding 
site architecture for Sudlow's Site I, a specialized cavity in subdomain IIA which 
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Figure 25. Tryptophan fluorescence spectra of (A) HSA, (B) RbSA, (C) 
GSA, (D) SSA and (E) BuSA. Letters n, g, a and s represent native, 
acetylated, guanidinated and succinylated albumin derivatives respectively. 
The spectra were recorded after exciting the protein at 295 nm. Slits were 
2 and 3 nm for excitation and emission respectively. 
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accommodates at least one tryptophan residue (Sudlow et al., 1976; Carter & Ho, 
1994). 
A significant (12-26%) decrease in tryptophan fluorescence observed in different 
albtunins upon acetylation or succmylation can be ascribed to the restriclion / 
alteration of the mobility of indole side chain of tryptophan due to altered 
environment induced by the attached acetyl or succinyl groups. Marked blue shift 
in the emission maxima of different acetylated or succinylated albumins indicated 
changes in the dielectric microenvironment aroimd tryptophan towards more 
hydrophobic or apolar (Sjoholm & Ljungstedt, 1973; Doekal et at., 2000). This 
seems to be understandable as positive charge of lysine residues is abolished in 
acetylated preparations and substituted with a negative charge in succinylated 
derivatives and the presence of acetyl or succinyl groups will certainly increase the 
hydrophobicity of the binding pocket. These results also suggest the invOlvettlent of 
buried lysine residues in salt bridge(s) formation witii oppositely charged groups. 
Mekemtm s£^ 
Interdomain associations involving hydrophobic as well as salt bridge interactions play 
important role in the maintenance of native three dirnensional conformation of 
* 
albumin (Doekal et al., 2000). Two such salt bridges, involving Lys-190 and Lys-205 
in association with Glu-425 and Glu-465 respectively have been found in a high-
resolution crystal structure of HSA (Carter Sc Ho, 1994). Covalent blocking of few 
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such lysine residues in albumin by acetylation or succinylation would abolish some of 
the intramolecular and interdomain interactions and thus may afifect native protein 
conformation and/or molecular size (Ansari et al., 1975). The effect may be more 
significant in the case of succinyl group incorporation (which replaces a positive 
charge on lysine residues with a negative charge) due to charge-charge repulsion as 
well as steric hindrance caused by succinyl groups (Ansari et al, 1975; Kidwai et al, 
1976). This can be clearly seen from the values of Stokes radius for different 
albimuns and their modified derivatives obtained from analytical gel filtration data (see 
Table 4). HSA and SSA have littie higher molecular size, with a Stokes radius of 
~3.56 imi each compared to RbSA which is smaller having a Stokes radius of 3.35 
nm. Although, all serum albumins showed increase in Stokes radius upon 
succinylation, the effect of acetylation on the Stokes radius was seen in some cases 
(Table 4). The increase in Stokes radius of different serum albumins upon 
succinylation of their buried lysine residues was in agreement with an earlier report on 
BSA(Mire?a/.,1992). 
Binding of bilirubin to different serum albimuns and their modified derivatives was 
studied by fluorescence quench tifration, absorption and CD spectroscopy. Using 
fluorescence quench titration method and by fitting the data into Scatchard plots 
(Figures 26-30), we found comparable values of association constant, A^a (1-42 xlO' -
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Table 4 
Gel filtration data of different serum albumins and their modified derivatives obtained 
on a Seralose-6B column (80 x 1.15cm) at pH 7.4. 
Albumin 
derivatives 
HSA 
gHSA 
aHSA 
sHSA 
RbSA 
gRbSA 
aRbSA 
sRbSA 
GSA 
gGSA 
aGSA 
sGSA 
SSA 
gSSA 
aSSA 
sSSA 
BuSA 
gBuSA 
aBuSA 
sBuSA 
Elution volume 
(ml) 
259 
259 
259 
257 
263 
263 
260 
258 
260 
261 
260 
258 
259 
259 
257 
256 
261 
261 
259 
258 
(-logKj'' 
0.4269 
0.4269 
0.4269 
0.4362 
0.4123 
0.4123 
0.4233 
0.4305 
0.4233 
0.4196 
0.4233 
0.4305 
0.4269 
0.4269 
0.4362 
0.4378 
0.4196 
0.4196 
0.4269 
0.4305 
erfc^'K, 
0.2829 
0.2829 
0.2829 
0.2873 
0.2596 
0.2596 
0.2731 
0.2832 
0.2731 
0.2689 
0.2731 
0.2832 
0.2829 
0.2829 
0.2873 
0.2921 
0.2689 
0.2689 
0.2829 
0.2832 
Stokes radius^ 
(nm) 
3.56 
3.56 
3.56 
3.64 
3.35 
3.35 
3.49 
3.58 
3.49 
3.45 
3.49 
3.58 
3.56 
3.56 
3.64 
3.67 
3.45 
3.45 
3.56 
3.58 
Values of Stokes radius represent a mean of two data sets analyzed according to equation (3) and (4) 
respectivefy as mentioned in the 'Materials and Methods' section. 
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2.03 xlO^ lit. mol"^ ) of bilirubin for the primary binding site on different serum 
albumins as shown in Table 5. These values were in agreement with the previously 
published values of 1.56x10^ and 1.57x10^ lit. mol"^  reported for HSA and BSA 
respectively (Berde et al, 1979; Mir et ah, 1992). The value of JTa decreased 
significantly (>5 fold) upon acetylation or succinylation of internal lysine residues of 
different serum albiunins being much higher (-21 fold) in RbSA (see Table 5). On 
the other hand, guanidinated albumin derivatives gave more or less similar values ofiTa 
as obtained with native albumins. In an earlier report, severe decrease in Kg, value of 
bilirubin binding has also been shown upon acetylation or succinylation of internal 
lysine residues of BSA (Mir et al, 1992). The decreased affinity of acetylated / 
succinylated albimiin derivatives for bilirubin can be attributed to the abolishment of 
positive charge on critical lysine residues of these albiunins. 
Free or unbound bilirubin gave the absorption spectrum in the wavelength range 
380-550 nm with a maxima (A a^x) around 440 nm. The absorption maxima shifted 
towards higher wavelength (red shift) and absorbance increased significantly when 
albumin was added to the bilirubin solution. Both increase in absorption and red shift 
in the absorption maxima were indicative of the pigment binding to albumin (Harmatz 
& Blauer, 1975; Jacobsen & Brodersen, 1983; Tayyab et al, 1995). Figures 31-35 
show absorption spectra of bilirubin complexed with various native albumins and their 
covalent derivatives. Values of Xmaxas well as molar absorption coefficient at X^,^ 
of various complexes of bilirubin with albumins and their modified derivatives are 
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Table 5 
Visible range spectral data of bilirubin (lO^M) bound to different native albumins and 
their modified derivatives (20^M) measured in 0.06M sodium phosphate buffer, pH 8.0, 
ionic strength 0.15. 
Albumin 
derivatives 
HSA 
gHSA 
aHSA 
sHSA 
RbSA 
gRbSA 
aRbSA 
sRbSA 
GSA 
gGSA 
aGSA 
sGSA 
SSA 
gSSA 
aSSA 
sSSA 
BuSA 
gBuSA 
aBuSA 
sBuSA 
Molar absorption" 
coefficient 
(ex 10-') 
0.685 (468) 
0.652 (467) 
0.563 (456) 
0.533 (454) 
0.721 (464) 
0.695 (563) 
0.560 (452) 
0.546(450) 
0.725 (472) 
0.699 (468) 
0.560 (460) 
0.503 (456) 
0.657 (466) 
0.619(466) 
0.506 (456) 
0.452(451) 
0.645 (468) 
0.605 (464) 
0.510(456) 
0.464 (448) 
Ka 
(lit. mot') 
1.50x10^ 
1.30x10' 
1.90x10* 
1.50x10* 
2.03 xlO' 
1.68x10' 
1.07x10* 
0.97 xlO* 
1.51 xlO' 
0.60x10' 
1.09x10* 
1.02x10* 
1.42x10' 
1.00x10' 
2.67x10* 
2.10x10* 
1.61x10' 
ad 
0.91 xlO* 
nd 
Molar ellipticities and position of CD 
band maxima 
parentheses!' 
30.73 (460) 
26.00 (460) 
19.11(462) 
13.12(454) 
33.80(458) 
32.26(461) 
17.00 (454) 
13.20(466) 
— 
— 
12.40 (444) 
12.00 (458) 
— 
"^ 
16.10(464) 
22.30 (466) 
— 
— 
10.70 (486) 
19.00(470) 
and minima (nm) in 
-24.12(409) 
-21.40(409) 
-14.21(411) 
-11.15(409) 
-32.00(413) 
-31.16(416) 
-14.04(412) 
-09.16 (414) 
-36.26 (426) 
-31.00(464) 
-30.40 (428) 
-13.00 (409) 
-08.00 (400) 
-38.20 (472) 
-25.00 (414) 
-31.60(430) 
-18.30 (409) 
-12.00(411) 
-36.10(454) 
-34.20 (450) 
-31.40(433) 
-24.10(411) 
'Values of molar absorption coeflScient (e) were calculated at X^SK with respect to native albumin-bilirubin 
complexes and are expressed as € x 10"' NT' cm"'. The concentration of bilirubin and albumin were 10|aM and 
20|iM respectively. Values of>^,^ are given in parentheses. 
"Values of molar ellipticity were calculated with respect to the total bilirubin present in the solution and are 
expressed as [9] x 10 (deg. cm .^ dmol"'). 
nd: not determined 
0.8 -
^ 0.6 
E o 
o 
X 
0.4 
0.2 
pi < , 
'•' ' ' 
^S°oooo"^ 
\ 
^ ft o 
X 
400 440 480 520 
Wavelength, nm 
560 
Figure 31. Visible absorption spectra of bilirubin complexed with HSA (•) 
and its modified derivatives viz. gHSA (o), aHSA (•) and sHSA (Q). 
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Figure 34. Visible absorption spectra of bilirubin complexed with SSA (•) 
and its modified derivatives viz. gSSA (o), aSSA (•) and sSSA (°). 
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Figure 35. Visible absorption spectra of bilirubin complexed with BuSA (•) 
and its modified derivatives viz. gBuSA (o), aBuSA (•) and sBuSA (o). 
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given in Table 5. As is evident from Figures 31-35 and Table 5, all serum albumins 
produced a strong red shift of about 24-32 mn in the absorption maxima of bilirubin 
upon binding which was in agreement with earlier observations (Harmatz & Blauer, 
1975; Jacobsen, 1977; Berde etal, 1979; Tayyab & Qasim, 1987). The complexes of 
bilirubin with guanidinated derivatives of these albumins showed somewhat 
similar characteristics (with little variation) as observed with native albumin-bilirubin 
complexes. On the other hand, complexes of bilirubin with both acetylated and 
succinylated derivatives showed a red shift of about 12-20 nm and 8-16 nm 
respectively. Decrease in the extent of red shift as well as molar absorption 
coefficient (see Table 5) of the complexes of bilirubin with acetylated and 
succinylated derivatives of different albimains suggested the role of positive charge on 
internal lysine residues of these albumins in bilirubin-albumin interaction. This was in 
agreement with previous reports showing the involvement of electrostatic interactions 
in bilirubin binding to albumin (Jacobsen, 1977; Roosdorp et al.,\911). 
In view of the two half-domain model of primary bilirubin binding site on albumin 
in which each dipyrrole unit of the pigment binds to separate subdomains of 
albumin making a dihedral angle and thus leading to exciton splitting which results 
in changes in the absorption spectrum of bilirubin (Jacobsen & Brodersen, 1983; 
Lightner et ah, 1986; 1988), the alterations in absorption spectrum of bilirubin 
complexed with acetylated or succinylated albvmiin derivatives compared to that 
obtained with native or guanidinated albumins can be ascribed to the shifting of 
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dihedral angle and thereby the exciton splitting among the two chromophores which 
brought about significant changes in the conformation of the bound pigment. Similar 
changes have also been noticed on lowering the pH of bilirubin-albumin solution 
(Harmatz & Blauer, 1975; Jacobsen & Brodersen, 1983). 
Figures 36-40 show the effect of internal lysine modification of serum albimiins on 
the CD spectrum of bilirubin boimd to high affinity site in these albumins. As can be 
seen from Figiu-es 36 and 37, curve n, complexes of bilirubin with native HSA and 
RbSA showed bisignate CD spectra characterized by a positive CD Cotton effect 
(CDCE) at higher wavelength and negative CDCE at shorter wavelength. These 
observations were similar to those reported earlier (Harmatz & Blauer, 1975; Lightner 
et al, 1986; 1988) suggesting that the pigment binds to these albumins in a folded 
conformation with positive chirality. Acetylation or succinylation of internal lysine 
residues in these albimains, though did not change the sign order and shape of the 
bisignate CD spectra but severely decreased the intensity of both positive and 
negative CDCEs (Figures 36 and 37, curves a and s and Table 5). In acetylated and 
succinylated RbSAs, the band maxima were also slightly shifted from their actual 
positions (Table 5). Nearly 50% (or more) reduction in the originalintensity of CD 
band maxima and minima were noticed in both HSA and RbSA upon acetylation and 
succinylation of internal lysine residues whereas guanidination resulted in small 
changes in the CDCEs' intensity (Figures 36 and 37, curve g ). The altered CD specfra 
of bilirubin boimd to acetylated and succinylated albmnins was in agreement with 
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earlier observations (Lightner et al, 1988) on the binding of various bilirubin isomers 
(haAmig their carboxyl groups modified) to HSA. These isomers unlike parent 
bilirubin molecule generated weak CDCEs when bound to the same high afFmity 
binding site on HSA indicating weak enantioselection in the absence of salt 
linkages. In view of this, our results also suggested the involvement of salt linkages 
existing between S-NH2 groups of internal lysine residues and carboxyl groups of 
bilirubin in the enantioselective incorporation of bilirubin into high affinity site on 
these serum albimiins. 
CD spectral results on the binding of bilirubin to covalent derivatives of GSA, SSA 
and BuSA were interesting. As can be seen fi-om Figures 38, 39 and 40, 
characteristic monosignate CD spectra of bilirubin bound to native GSA, SSA or 
BuSA were transformed into bisignate CD spectra upon acetylation and succinylation 
(curves a and s respectively) of internal lysine residues in these albimiins. The 
transformed CD spectra showed CD band minima (-) at shorter wavelength and 
maxima (+) at higher wavelength as compared to their native coimterparts showing 
only monosignate negative CDCEs at higher wavelength (Table 5). The intensities of 
both positive and negative CDCEs of the transformed bisignate CD spectra were 
decreased significantly. These spectral characteristics were similar to the bisignate 
CD spectra of bilirubia-HSA or bilirubiu-RbSA complexes (Figures 36 and 37, 
curve n). On the other hand, guanidination of internal lysine residues of these 
albumins (GSA, SSA and BuSA) did not change the shape and sign order of the 
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characteristic monosignate CD spectra of bound bilirubin but a shift in the CD band 
maxima and a slight decrease in the CDCE intensities were noticed (Figures 38, 39 
and 40, curve g). It may be recalled that acetylation neutralizes the positive charge on 
e-NH2 groups of lysine residues whereas succinylation replaces the positive charge 
with a negative charge and in both cases, CD spectra of bound bilirubin were severely 
perturbed. On the other hand, guanidination of albumins where positive charge is 
retained on lysine residues, did not significantiy alter the CD spectia of bilirubin-
albumin complexes. From these results it appears that the presence of positive charge 
on internal lysine residue(s) plays an important role in the stereoselective binding of 
bilirubin involving salt linkage(s) between carboxyl groups of bilirubin and lysine 
residues of albumins and the absence of positive charge on these lysrue residues (as 
foimd in acetylated and succinylated albumins) severely affects its chirality. The 
# 
alteration in the chirality of the pigment bound to acetylated or succinylated albimiin 
derivatives seems to be brought about by the change in the dihedral angle between the 
two chromophores of the bound pigment from the angle at which they are fixed 
when bilirubin is boimd to native or guanidinated albiraiin derivatives. 
Based on the bilirubin binding results described above, we showed the decrease in 
bilirubin binding affinity of different serum albimiins upon acetylation and 
succinylation of internal lysine residues. To further assess the binding affinity, we 
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studied ihe switching of bound bilirabin from modified albumin derivatives to 
native albimiins of the same species using CD spectroscopy. As can be seen from 
Figure 41A and B, bisignate CD spectra of the complexes of bilirubin with acetylated 
derivatives (curve 1) of both GSA and SSA were transformed to monosignate 
spectra (curve 2) after the addition of free GSA or SSA to these complexes. 
Monosignate CD spectra had the same characteristics as given by the complexes of 
bilirubin with native albimiins. This indicated switching of bound bilirubin from 
acetylated GSA or SSA derivatives towards native albumins. Similar results were 
also obtained with succinylated derivatives of these albumins (figure omitted for 
clarity). No reversal in the switching of boimd bilirabin from native GSA or SSA to 
acetylated or succinylated GSA or SSA derivatives was noticed upon addition of these 
derivatives to a solution containing bilirabin and native albumins (data not shown). 
These results suggested that acetylation and succinylation of internal lysine residues 
significantly altered the binding site geometry such that the ligand was not tightly 
bound and therefore switched rapidly to high affinity binding site available on native 
albumins. 
Involvement of lysine residue(s) in salt bridge(s) formation with carboxyl groups of 
bilirubin in bilirabin-albumin interaction was also studied by CD spectroscopy in the 
presence of chloroform as this anesthetic binds to the same high affinity bilirubin 
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Figure 41. [A] Curve 1, CD spectrum of a bilirubin solution (lOuM) 
containing acetylated GSA (20[iM) recorded after 30-40min incubation of 
bilirubin-albumin solution in dark. Curve 2 represents CD spectra of the 
same solution after the addition of ~20(iM of native GSA. [B] Curves 1 
and 2 represent the CD spectral measurements involving acetylated and 
native SSA under similar experimental conditions as mentioned in the 
legend to Figure 41 A. 
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binding site in albumins and alters the chirality of the bound pigment (McDonagh et 
al, 1992; Pu e? al, 1993; Patra & Pal, 1997). The effect of chloroform on the CD 
spectra of bilirubin bound to different native albumins and their modified derivatives is 
shown in Figures 42-46. As can be seen from these figures, addition of a small amount 
of chloroform to the bilirubin-albumin solution, completely inverted the bisignate CD 
spectra of bilirubin complexed with HSA or RbSA (curve n of Figures 42 and 43 
respectively). It also transformed the monosignate CD spectra of bUirubin complexed 
with GSA, SSA or BuSA into bisignate CD spectra (curve n of Figures 44, 45 and 46 
respectively) similar to those obtained with a chloroform free solution of bHirubin-
HSA and bilirubin-RbSA complexes (Figures 36 and 37 respectively, curve n). These 
observations were in agreement with previous reports suggesting that chloroform 
potentially alters the hydrophobic microenvironment of the binding site and thereby 
chirality of the boimd pigment (McDonagh ef a/., 1992; Vnetal, 1993). As is clearly 
indicated from Figures 42, 44, 45 and 46 (curve n), there was an increase in the 
intensities of both positive and negative CDCEs of bilirubin complexed with HSA, 
GSA, SSA and BuSA, being much higher in case of bilirubin-SSA complex after 
chloroform addition as compared to the one obtained in the absence of chloroform. 
However, bUirubin-RbSA complex showed a decrease in the CDCEs' intensity (Figure 
43, cmve n) though the inversion of CD spectrum was similar to some extent to that 
of bilirubin-HSA complex. Increase in CDCEs' intensity upon chloroform addition to 
the complexes of bilirubin with guanidinated derivatives of these albumins was also 
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Figure 46. Effect of chlorofonn (~20mM) on the CD spectra of 
bilirubin (lO^M) complexed with BuSA and its modified 
derivatives {20nM). Letters n, g, a and S stand for native, 
guanidinated, acetylated and succinylated BuSA derivatives 
respectively. 
105 
found to be similar to those obtained in case of bilirubin complexed with native 
albumins (Figures 42-46, curve g). The inversion and transformation of the CD 
spectra of different bilirubin-albumin complexes in the presence of chloroform can be 
attributed to the change in the stereochemistry of the bound pigment (Pu et al, 1993). 
This change in the stereochemistry apparently favors the binding of bilirubin with a 
positive (P) chirality conformation (Lightner et al, 1986; 1988) with enhanced 
enantioselectivity in the case of GSA, SSA and BuSA and with a negative {M) 
chirality conformation in HSA and RbSA (Pu et al., 1993). Interestingly, the CD 
spectra of bilirubin complexed with acetylated or succinylated derivatives became 
insensitive to the presence of chloroform. Addition of chloroform to the complexes of 
bilirubin_with_acetylated and succinylated-derivatives of theie albumins (curves a 
and s respectively of Figures 42-46), drastically reduced the intensity of both positive 
and negative CDCEs being close to complete abolishment in case of GSA and 
RbSA. Further, except HSA (Figure 42), chloroform did not invert the bisignate CD 
spectra of bilirubin complexed with acetylated and succinylated derivatives of other 
albumins (curves a and s of Figvu-es 43-46). These observations clearly suggest that 
the precise location and orientation of positively charged e-NH2 groups of lysine 
residue(s) at the ligand binding site and their involvement in salt bridge(s) formation 
with carboxyl group(s) of bilirubin are crucial for efficient and effective 
stereochemical changes in the bound pigment brought about by co-binding of 
chloroform(McDonaghera/., 1992; Puera/., 1993; Pati-a&Pal, 1997). 
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From the above results it can be said that one or two of the iatemal lysine residue(s) 
of these serum albiunins play an important role in bilirubin-albumin interaction 
through salt bridge(s) formation with oppositely charged carboxyl groups of bilirubin. 
The replacement of positive charge on these lysine residues severely perturbed the 
enantiomeric stereoselectivity of ligand at high affinity site on these albumins. 
M^ts&kemkat cdottg^ qf&Mftikia hemtd U MSd (tad its dmvativeis 
When an equimolar (1:1) complex of bilirubin with HSA was irradiated under white 
light for different time periods (0-30 minutes), the absorbance decreased continuously 
with a slight shift (5 nm) in the absorption maxima (Figure 47). Guanidinated HSA 
showed a similar pattern to that observed with native HSA, however, the blue shift was 
more significant (1 l-nm)-after irradiation for 30 minutes._0n the other.hand, imder 
similar conditions, a brief irradiation (2 minutes) of the complex of bilirubin with 
either aHSA or sHSA produced a significant rapid shift of 15 nm in the absorption 
maxima towards a shorter wavelength which continued up to 4-5 minutes and then 
became constant at 435 nm and 434 nm in aHSA and sHSA, respectively (Figure 47). 
A decrease in absorbance as well as the blue shift observed in the absorption spectrum 
of the bilirubin-HSA complex upon irradiation can be ascribed to the photoconversion 
of bilirubin into photobilirabins. A marked blue shift observed in the bilirubin-aHSA 
and bilirubin-sHSA complexes after 4 minutes irradiation seems to be due to the fast 
conversion of bilirubin into cyclobilimbin which absorbs at 435 nm (Migliorini et al. 
10 20 30 
Time, min 
40 
Figure 47. Effect of time on the absorption maxima (k„^) of bilirubin 
complexed with HSA (•) and its modified derivatives viz. gHSA (°), 
aHSA (•) and sHSA (°) upon irradiation with white light. 
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1988). In view of the involvement of electrostatic interactions between a negatively 
charged bilirubin dianion and positively charged lysine residues of albumin in the 
bUirubin-albumin interaction, it seems reasonable that this salt linkage provides some 
stability to the bilirubin chromophore which is lost when it is broken as found in the 
case of aHSA and sHSA, respectively. These results indicated that a brief irradiation 
of the complex of bilirubin with either aHSA or sHSA weakened this interaction and 
bilirubin bound to these derivatives then followed a photochemical path similar to that 
of free bilirubin. However, no significant shift (Figure 47) in the absorption maxima 
was noticed, even up to 15 minutes irradiation of an equimolar complex of bilirubin 
with HSA, though the absorbance decreased continuously. A similar pattern was 
shown by gHSA (Figure 47) in which a small shift was observed upon 30 minutes 
irradiation. These results suggest the role of salt bridges provided by e-NH2 groups _ 
of lysine residues of HSA and bilirubin dianion in the kinetics of photoisomerization 
of the bound pigment. Taken together, the results obtained in earlier studies (Onishi et 
al, 1980; 1985; Lamolaera/., 1981; McDonagh etal, 1982; 1989; Costarino ef a/., 
1985) and our results on photochemical changes of bilirubin boimd to aHSA and 
sHSA, it appears likely that 8-NH2 groups of lysine residues in the primary bilirubin 
binding site of HSA, are directly involved in stereospecific and regioselective 
photoisomerization of bound bilirubin. 
Figure 48A shows the efifect of visible light on the induced fluorescence of 
bilirubin boimd to HSA and its derivatives. As can be seen from the figure, continuous 
Time.min 
Figure 48. [A] change in fluorescence intensity of bilimbin-albumin 
complexes (20nM albumin and lO i^M bilirubin) at 530 nm as a function of 
dose of irradiation at 468nm. Curves 1, 2, 3 and 4 represent the fluorescence 
spectra of bilirubin-HSA, bilirubin-gHSA, bilirubin-aHSA and bilirubin-
sHSA complexes respectively. [B] fluorescence intensity change was 
recorded under identical conditions as in Figure A but the solutions 
contained ~20mM chloroform in each sample. 
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irradiation of the samples in spectrofluorometer at 468 nin up to 20 minutes led to a 
small decrease or no change for 2 minutes followed by a continuous increase in the 
fluorescence intensity in both bilirubin-HSA (curve 1) and bilirubin-gHSA (curve 2) 
complexes. Astonishingly, when bilirubin-aHSA or bilirubin-sHSA complexes 
(curves 3 and 4 of Figure 48 A) were irradiated under similar experimental conditions, 
there was no significant change in the fluorescence intensity. Further, increasing the 
time of irradiation up to 1 hour did not affect the fluorescence intensity of these 
complexes. Similar pattern of the change in fluorescence intensity was observed when 
the samples were irradiated at 440 nm (data not shown). Since bilirubin bound to 
HSA shows maximum absorbance at 468 run whereas unboimd bilirubin absorbs 
maximally at 440 nm, this wavelength was selected to irradiate the samples of bound 
bilirubin to preclude the involvement of free bilirubin in these changes. It is of 
importance to note that neither free (unbound) bilirubin fluoresces (Chen, 1973; 
1974) nor the fluorescence is induced when continuously irradiated at fliese 
wavelengths. The fluorescence enhancement seen in bilirubin-HSA complex upon 
photoirradiation was in good agreement with earlier findings (Lamola e? a/., 1981; 
1982). Complex of bilirubin with gHSA derivative (in which positive charge was 
retained on critical lysine residues) showed similar behavior upon photoirradiation. 
On the other hand, photoinduced fluorescence enhancement of bound bilirubin was 
completely ceased in both acetylated and succinylated HSA derivatives in which 
positive charge on critical lysine residues was abolished and replaced by zero charge 
I l l 
and a negative charge respectively. Here, it is important to note that bilirubin bound 
to these derivatives (aHSA and sHSA) showed bisignate CD spectrum similar to the 
one obtained with native HSA (Figure 36). However, concomitant modulations in the 
bisignate CD spectrum of bilirubin complexed to these derivatives were noticed upon 
photoirradiation (Figure 49A and B). These results reflected the importance of 
positive charge on e-NH2 groups of lysine residues of the protein, involved in salt 
linkage(s) formation with the carboxyl groups of bilirubin as predicted earlier 
(Lightaere^a/., 1986; 1988) as their masking can markedly alter the dynamics and 
stereoselectivity of photoinduced asymmetric transformation of the bound pigment. 
Several lines of evidence suggest that high affinity bilirubin binding site on HSA is 
located in the protein interior corresponding to a hydrophobic pocket in subdomain 
HA (Carter & Ho, 1994). This region is highly stable and is generally not 
destabilized by urea and even at extremely low pH, this region is characterized by 
abundant secondary structure and few native like tertiary folds (Muzammil e? a/., 
1999; 2000; Dockal et al, 2000). Therefore, one may argue that covalent masking of 
critical lysine residues located in this region by bulky and sterically unfavorable 
acetyl, succinyl and guanidino groups may induce structural alterations in the protein 
which may decrease the affinity of bilirubin for the primary binding site and therefore 
bilirubin probably sinks into secondary low affinity sites where its photoinduced 
spectral properties are not comparable to those observed when bound to primary high 
affinity site. This seems unlikely for two reasons: first as characterized by far-UV 
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Figure 49. CD spectral changes accompanied by irradiation of bilirubin 
compiexed with, [A] HSA (lOpiM albumin and 5|xM bilirubin) and [B] 
aHSA (11.5|iM albumin and 6nM bilirubin). Dose of irradiation from top to 
bottom was: 0, 1, 2, 3, 6, 10, 15 and 30 min. [C] and [D] show the effect 
of chloroform (~20mM) on the CD spectral changes of bilirubin-HS A and 
bilirubin-aHSA complexes respectively. Dose of irradiation from bottom 
to top was: 0, 2, 6,15 and 30min. 
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CD measurements, no detectable secondary stractural changes were induced in HSA 
by covalent modification though near-UV CD spectra of aHSA and sHSA were only 
slightly perturbed (Figure 20A and B respectively) and second that photoinduced 
spectral modulations were not due to the binding of bilirubin to secondary low 
affinity site(s) because with all the HSA derivatives, CD spectrum of bound bilirubin 
was completely inverted upon addition of chloroform (Figure 42) which evidently 
binds to subdomain HA in HSA (Eckenhofif, 1996; Johansson, 1997) where primary 
bilirubin binding site is located (Carter & Ho, 1994). Presence of chloroform caused 
a red shift of 3-13 nm in the position of inverted CD bands and decreased the intensity 
of both positive and negative CDCEs in case of bilirubin-aHSA and bilirubin-sHSA 
complexes (Figure 42). The decrease in CDCEs' intensity can not be ascribed to 
weaker chloroform binding to these derivatives (aHSA and sHSA) as similar 
quenching of tryptophan fluorescence was observed in these derivatives in the 
presence of chloroform (Figure 50). Chloroform at higher concentration (26mM) also 
produced a significant blue shift (-6-10 nm) in the tryptophan emission maxima of 
HSA (Figure 50) and its derivatives (figure omitted for brevity) which was indicative 
of the changes in the dielectric microenvironment (towards more apolar region) of 
indole ring in tryptophan (Johansson, 1997). These results suggest that inversion in 
the pigment chirality (as reflected by inverted CDCEs) and red shift in the CD band 
maxima are due to alterations in the hydrophobic microenvironment and internal 
topography of the primary pigment binding site induced by chloroform 
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Figure 50. Effect of chloroform on tryptophan fluorescence of HSA 
(5|aM) at pH 7.4. Chloroform concentration from top to bottom was 
varied as 0, 2, 4, 6, 8, 10, 18 and 26mM. Inset shows the tryptophan 
fluorescence quenching of (•) HSA and (n) aHSA at increasing 
chloroform concentration. Each data point was the average of three 
independent determinations. The protein was excited at 295nm and 
emission was recorded at 342nm. 
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(McDonagh et al, 1992; Pu et al, 1993). Addition of chloroform to the bilirubin-
albumin complexes also decreased the fluorescence yield of boimd bilirubin (Figure 
48B), being 50% of that seen in the absence of chloroform in case of bilirubin-aHSA 
and bilirubin-sHSA complexes (Figure 48B, curves 3 and 4). This indicates that 
bilirubin is stiU binding in HA subdomain of modified albumin and the decrease in 
fluorescence is due to chloroform binding in the close proximity of bilirubin 
(Johansson, 1997). From these results it appeared that it was not the specificity 
rather affinity of bilirubin for the primary binding site onHSA which was decreased 
by covalent modification. Since chloroform binds to different HSA derivatives with 
more or less equal affinity as that for native HSA as evident from the quenching 
results (Figure 50), it can be said that covalent blocking of S-NH2 groups particularly 
those located in the protein interior does not alter the anesthetic binding site which is 
hydrophobic in nature. Therefore, electrostatic rather than hydrophobic interactions 
seem to play an important role in the photoinduced spectral modulations of bound 
bilirubin in bilirubin-albumin complexes. 
The CD spectra of bilirubin complexed with different HSA derivatives (gHSA, 
aHSA and sHSA) were characterized by bisignate CDCEs (Figure 36, curves 2, 3 
and 4, respectively) similar to that bound to native HSA (Figure 36, curve 1). A 
brief (1 minute) irradiation of bilirubin bound to native HSA under white 
fluorescent light, produced only little change in the magnitude of both positive and 
negative CDCEs (Figure 49A). Similar changes were also observed in case of 
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bilirubin-gHSA complex (data not shown). On the other hand, drastic changes were 
observed in case of bilirubin bound to aHSA and sHSA in which a brief irradiation 
of the bound bilirubin under white fluorescent light, completely abolished the 
negative CDCEs while the intensity of positive CDCEs was moderately decreased 
and the band maxima shifted towards blue region (Figure 49B). As can be seen 
from Figure 49A and B, a 15 minutes dose of irradiation produced different results 
with bilirubin-HSA and bilirubin-aHSA complexes such that the spectra were 
characterized by monosignate CDCE of opposite sign which indicated that upon 
irradiation to white light, the bilirubin molecule in the binding pocket of HSA acquired 
different conformational state in the absence of salt bridge(s) (as foimd in aHSA and 
sHSA) compared to the one in which salt bridges were present (as found in HSA and 
gHSA). Presence of chloroform reconciled CD spectral modulations of bilirubin-
aHSA and bilirubin-sHSA complexes as similar photoinduced changes were noticed 
in the CD spectrum of bilirubin bound either to native HSA or its derivatives (Figure 
49C and D). In view of the stabilizing effect of chloroform on certain folded 
conformation of proteins (Tanner et al.,1999; Johansson et al, 1999), it can be said 
that stabilization of certain local regions at bilirubin binding site in aHSA and 
sHSA by chloroform, provides stability to the bound pigment against light as 
evident from identical CD spectral changes upon photoirradiation (Figure 49C and 
D). These observations suggest that anesthetics not only alter the local protein 
dynamics (Johansson et al., 1999) but also attenuate the dynamics or mobility of those 
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nearby bound ligands whose confonnation is sensitive (e.g., bilirubin) to the 
presence of anesthetics (Pu et al, 1993). Interestingly, chloroform-induced 
enantiomeric stabilization did not bring fluorescence of bilirubin-aHSA or bilirubin-
sHSA complexes (Figure 48B, curves 3 and 4) close to that produced by bilirubin-
HSA or bilirubin-gHSA complexes upon photoirradiation (Figure 48B, curves 1 
and 2). 
Bilirubin, a bichromophoric tetrapyrrole, is characterized by an extensive 
conjugated double bond system. Although imbound pigment absorbs strongly in the 
visible region, it does not fluoresce. The fluorescence is induced when it forms 
complexes with chiral binding agents like albumin (Chen, 1973; 1974). It has been 
suggested that the genesis of fluorescence in bound bilirubin is due to acquiring 
helical shape rather than hydrophobic stacking (Chen, 1973; 1974). Various 
bilirubin isomers also acquire a helical shape as revealed by induced fluorescence and 
circular dichroism (Lamolae/^a/., 1983; Lightnere^^/., 1986; 1988). Thus, once the 
fluorescence is induced upon binding to HSA due to helix formation, then what 
accounts for its further enhancement upon exposing the bound pigment to visible 
light? Conformational twisting of boimd bilirubin leading to configurational or 
structural isomerization (endo- vinyl cyclization) upon photoirradiation is well known 
(Lamola et al, 1981; 1982; 1983; McDonagh & Lightner, 1985). Whether these 
processes are fi^eely taking place or under some restrictions, and if restricted then by 
which force, is not very clear. From the results on the further enhancement of 
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fluorescence (Figure 48A, curves 1 and 2) and slow and steady decrease in positive 
CDCEs (Figure 49A) upon photoirradiation of bilinibin-HSA and bilirubin-gHSA 
complexes and the absence of these phenomena in both bilirubin-aHSA and bilimbin-
sHSA complexes (Figure 48A, curves 3 and 4 and Figure 49B), it seems that 
conformational twisting of bound bilirubin under some restrictions, posed by salt 
linkage(s) between E-NH2 groups of HSA and carboxyl groups of bilirubin, is 
responsible for photoinduced fluorescence enhancement. It has been reported 
earlier that photoirradiation of bilirubin boimd to albumin or free bilirubin dissolved 
in organic solvent (chloroform) results in the formation of the same photoisomerized 
species (Lamola et al., 1981). Thus, if photoisomerization is supposed to be the cause 
of fluorescence enhancement, then bilirubin dissolved in chloroform should also 
exhibit fluorescence upon photoirradiation. However, no fluorescence was induced in 
free bilirubin dissolved in chloroform upon photoirradiation, an observation which has 
been also been reported by earlier workers (Lamola et al, 1981; 1982; 1983). 
Interestingly, bilirubin bound to aHSA and sHSA though showed induced 
fluorescence but failed to produce any fiuther enhancement in fluorescence upon 
photoirradiation. Therefore, it is not merely the configurational or structural 
photoisomerization accompanied by delocalization of 7c-electrons of the pyrrole 
rings as well as vinyl groups ofboimd bilirubin responsible for fiirther enhancement 
of fluorescence. It appears that along with all these processes, the whole pigment is 
sterically strained due to salt linkage(s) formation involving its carboxyl groups 
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and 8-NH2 groups of protein and the two locally excited pyrromethanone 
chromophores (excitons) of the bound pigment held in a folded conformation 
(Lightner et al, 1986; 1988; Person et al, 1994), interacting strongly (exciton 
coupling) with each other by resonance splitting or the bound pigment undergoes 
tight helical twisting as the photoirradiation proceeds, causing the fluorescence to 
increase further (Figure 48A, curve 1). It has been reported that absorption of light 
by bilirubin leads to a faster photochemical reaction involving rotation of one of 
the end ring at 180 degree about the double bond followed by a slow reaction 
leading to cyclization of the pigment (Lamola et al, 1983; McDonagh & Lightner, 
1985). Photoirradiation is indeed accompanied by an initial small decrease in the 
fluorescence intensity of the boimd pigment followed by a slower increase several 
times higher than the initial fluorescence intensity, as shown earlier (Lamola et al, 
1981; 1982) and also observed in this study (Figure 48A). The slower increase in 
fluorescence was completely ceased in case of bilirubin-aHSA or bilirubin-sHSA 
complexes (Figure 48A, curves 3 and 4). These observations indicated that although 
bilirubin bound to aHSA or sHSA acquired similar folded conformation (helical) as 
observed with native HSA based on similarity in the bisignate CD spectrum as well 
as induced fluorescence upon binding to these derivatives (Figures 36 and 48A), this 
helicity did not in any way allow the fluorescence of bound bilirubin to increase 
further upon photoirradiation. It means that masking of critical E-NH2 groups in 
HSA thereby abolishing salt linkage(s) formation between bilirubin and HSA 
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(Lightner et al, 1988; Person et al, 1994) does not interfere with the binding of 
bilirubin in a folded ridge-tile conformation which is in corroboration with earlier 
findings on the binding of various bilirubin isomers to HSA (Lightner et al, 1986; 
1988). However, the instability of the bound pigment in bilirubin-aHSA and 
bilirubin-sHSA complexes was clearly reflected from a very rapid elimination of 
negative CDCEs upon photoirradiation for a brief time period. This seems to be 
possible as in the absence of salt linkage(s) between pigment and protein in tbese 
complexes, either one or both of the pyiromethanone imits of the bound bilirubin is 
(are) supposed to have more freedom to rotate at -CH^ -^ along with the rotation of 
one of the end pyrrole ring but this rotation is certainly different from that allowed 
when bovmd to native HSA. In this rotation, the two locally excited pyrromethanone 
chromophores either do not interact or interact very weakly, thereby causing 
alteration in the helicity due to which the fluorescence of boxmd bilirubin does not 
increase upon photoirradiation. This is understandable because when bilirubin 
complexed with aHSA or sHSA was photoirradiated briefly (1 minute), its bisignate 
CDCEs were rapidly transformed into monosignate CDCE of positive sign (Figure 
49B) akin to that exhibited by xanthobilirubin bound to HSA (Lamola et al, 1983; 
Lightner et al, 1986). This suggested that a brief photoirradiation of these complexes 
left only one half of bilirubin in contact with the binding site elements and the other 
half free in such a way that the phenomenon of exciton coupling / exciton interaction 
between the two excited pyrromethanone chromophores (Lightner e?a/., 1986; 1988; 
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Person et al., 1994) of the bound pigment did not occiu- and therefore, its fluorescence 
did not increase upon photoirradiation. This is exactly sinailar to xanthobilimbin 
bound to HSA showing induced fluorescence which does not increase further upon 
photoirradiation (Lamola et al., 19^3). 
Various binding forces have been suggested to facilitate the proper binding of 
bilirubin to HSA (Brodersen, 1979; 1982). Among these, chiral amine salt linkage(s) 
and associated intermolecular hydrogen bonds are considered to be the dominant 
forces involved in the enantioselective incorporation of the pigment at high affinity 
site (Brodersen, 1979; 1982; Lightner et al, 1986; 1988; Person et al., 1994). 
Results presented above revealed another important implication of salt linkage(s) 
present in bilirubin-HSA complex in the dynamics and stereoselectivity of 
photoinduced conformational changes in the bound pigment. Thus, Ihe precise 
location of 8-NH2 groups at the primary binding site on HSA is only one requirement 
for the binding orientation and enantioselectivity of the pigment (Lightner e? a/., 
1986; 1988); the other includes restriction of the conformational rotation of the 
bound pigment accessible by photoactivation. Since photoinduced excitation of 7t-
electrons may lead to partial or complete disruption of aromatic n-n van der Waals 
attractions existing between pyrromethanone chromophores of bilirubin and 
tryptophan and tyrosine residues of protein and therefore along with these van der 
Waals attractions, the secondary hydrogen bondings, i.e., not associated with salt 
linkages (Brodersen, 1979; 1982; McDonagh& Lightner, 1985; Lightner era/., 1986; 
122 
1988; Person et al, 1994); presumably seem insufficient to stabilize the boimd 
pigment against light in the absence of salt linkage(s). 
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On the modulation of photoinduced fluorescence enhancement and 
conformational stability of albumin-bound bilirubin: 
Effect of e-NH2 groups blocking and chloroform binding 
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Abstract 
Photoinduced fluorewence enhancement of bilirubin bound to primary binding site on human serum albumin (HSA) was completely 
ceased when t-NHj groups of its internal lysine residues were covalently blocked by acetylation or succinylation though the pigment bound 
to these derivatives in a folded conformation akin to thai bound to HSA. These photoinduced fluorescence modulations cannot be ascribed 
to the binding of bilirubin to secondary low afTmity sites as the CD spectrum of bilirubin bound to these derivatives showed complete 
inversion upon addition of chloroform which binds to subdomain HA in HSA where high affinity bilirubin binding site is located. Presence 
of chloroform reconciled the photoinduced alterations in the CD spectrum observed in its absence, suggesting that chloroform stabilized the 
bound ligand .against light but the fluorescence properties of bilirubin comptexed with acetylated or succinylated derivatives remained 
uiKhanged. Guanidinalion of internal E - N H : groups in HSA by 0-methylisourea did not alter the spectral properties of the bound ligand. 
These results suggest that !aliilinkage(s) existing between t-NHj groups of lysine residues in HSA and carboxyl groups ofbilirubin, »ct(f) as 
• potential barrier during conformational rotation of the bound ligand assisted by photoactivation and their abolishment can alter its 
dynamics and stereoselectivity, a hitherto unnoticed implication of salt|linkage(s) in BR-HSA complex. O 2000 Elsevier Sdence B.V. All 
rights reserved. 
Keywords: Albumin-bound bilirubin: 
Photoirradiation; Salt linkage 
Chemical modification; Chloroform-induced stabilization; Conformational dynamics: Fluorescence modulation; 
1. Introduction 
Bilirubin (BR), the principal degradation product of 
heme metabolism in mammals is transported to the liver 
by albumin for conjugation and subsequent excretion from 
the body Jl-3]. The binding of BR lo human serum albu-
min (HSA) has been a long term discussion with reference 
to the, binding forces involved in BR-HSA interaction, 
nature of the binding site and conformation of the bound 
pigment (4-7J. As revealed by circular dichroism (CD) 
spectroscopy that BR binds to HSA in a dissymmetric 
folded ridge-tile conformation {6.7). In this conformation, 
the bound pigment shows bisignate CD Cotton effects 
(CDCEs). a characteristic of intramolecular exciton cou-
pling between two pyrromethanonc chromophores and ex-
hibits greatly increased fluorescence [6.8]. Though BR con-
' • Conetpondini author. Fax: +91-571.701081; 
> E^nail: b(inmu*@nde.vnil.net 
sists of extensive conjugated double bond system but it is 
the helix formation in the pigment upon binding to albu-
min that has been suggested to be the cause of induced 
fluorescence (8,9). The fluorescence of albumin bound BR 
further increased when irradiated under visible fa'ght 
whereas intensity of CDCEs of the bound pigment de-
creased significamly (10,11). Recently we have reported 
that covalent modification of e-NH} groups of critical ly-
sine residues in HSA (involved in saltjlinkage(s) formation 
with carboxyl groups of BR) by acetylation or succinyla-
tion changed the pattern of photoinduced alterations in 
the CD as well as fluorescence spectra of the bound pig-
ment (12). The fluorescence of BR bound to acetylated or 
succinylated HSA derivatives did not increase when irra-
diated under white fluorescent light for varying times 
though the pigment bound to these derivatives showed 
bisignate CDCEs suggesting the binding of a folded 
ridge-tile conformcr with positive (P) diirality akin to 
that bound to native HSA (6,7). There is uncertainty 
that whether BR binds to the same high affinity site on 
03O4-il<Sf(n/S - lee front matter C 2000 Elsevier Science B.V. All righti reserved. 
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Role of salt bridge(s) in the binding and photoconversion 
of bilirubin bound to high affinity site 
on human serum albumin 
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Abstract 
The role of salt bridge(s) (between e-NH2 groups of lysine residues of human serum albumin (HSA) and carboxyl groups 
of bilirubin) in the binding and photoconversion of bilirubin bound to high affinity site on HSA was investigated by cx)valent 
modification of ~20% internal (buried) lysine residues of HSA with acetic anhydride, succinic anhydride and O-
methylisourea and white light irradiation of their complexes with bilirubin. The different HSA derivatives, namely, acetylated 
HSA (aHSA), succinylated HSA (sHSA) and guanidinated HSA (gHSA), thus obtained, were found to be homogeneous with 
respect to charge and size and characterized in detail in terms of mean residue ellipticity, Stokes radius, tryptophan 
fluorescence, bilirubin binding and the photochemistry of their complexes with bilirubin. All the three derivatives retained 
heUcal contents and molecular size (Stokes radius) similar to HSA except for sHSA which showed a slight increase in the 
Stokes radius from 3.56 to 3.64 nm. Further, fluorescence properties of aHSA and sHSA were also found to be different from 
HSA and gHSA. Based on difference spectral change, fluorescence quenching and fluorescence enhancement results of 
biUrubin bound to HSA and its derivatives, nearly 46 and 48% reduction in bilirubin binding was observed in the case of 
aHSA and sHSA, respectively. Both aHSA and sHSA showed a decrease of 8- and 10-fold, respectively, in association 
constant compared to native HSA. Although the bisignate circular dichroism (CD) spectra of an equimolar (1:1) bilirubin-
HSA complex was retained by all three HSA derivatives, the intensity of both positive and negative CD Cotton effects 
decreased significantly in both aHSA and sHSA. gHSA which retained net charge identical to native HSA, showed httle 
decrease in bilirubin binding and the intensity of bisignate CD Cotton effects. The photochemical reaction of bilirubin bound 
to aHSA and sHSA produced opposite results to those observed with HSA and gHSA. A brief (2 min) irradiation of an 
equimolar complex of bilirubin with both aHSA and sHSA accompanied a rapid shift (14-15 nm) in the absorption spectrum 
of the bound pigment towards the blue region and almost complete elimination of negative CD Cotton effects while only 
moderately affecting the magnitude of positive CD Cotton effects. On the other hand, similar treatment of the complexes of 
biUrubin with HSA and gHSA did not show any change in the absorption spectrum, only a slight decrease in the intensity of 
both positive and negative CD Cotton effects was observed. The fluorescence intensity of biUrubin bound to HSA and gHSA 
was increased upon irradiation with white Ught and after 30 min it was nearly twice the value observed at 0 min irradiation. 
Interestingly, no change in the fluorescence intensity of bilirubin bound either to aHSA or sHSA was observed upon 
irradiation, even on increasing the duration of irradiation to 1 h. Taken together, the results on fluorescence quenching, 
fluorescence enhancement, CD spectral changes and visible absorption spectroscopy suggest that salt bridge(s) of the type 
* Corresponding author. Fax: +91-571-101081; E-mail: btisamualgjnde.vsnl.net.in 
' Present address: Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta, GA 30912, USA. 
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Chloroform-induced conformational changes in the bound pigment 
in bilirubin-albumin complexes 
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Inlenliscipliiiiiiy Biol('(iiiu>l(),i;y Unit. Alii;<irli Muslim University. Alii;arli 202002, U.P.. India 
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jstract— Chloroform-induced conformalional chatigcs (if bilirubin (BR) bound lo ditVereni serum albumins were studied b\ 
•cular dichroism (CD) and fluorescence speclroscopy. Addition of a sj7iall amount of chloroform (= 20 mM) to a solution containing 
I [xM albumin and 15 |JM BR changed the sign order and magnitude of the characteristic CD spectra of all BR-albumin complexes 
cept BR-PSA complex which showed abnormal behavior. Monosignate negative CD Cotton effects (CDCEs) of BR complexed with 
iA. GSA and BuSA were transformed into bisignate CDCEs in presence of chloroform akin to those exhibited by chloroform free 
lution of BR-HSA complex, indicating that the pigment acquired right handed plus (P) chirality when chloroform was added to these 
•mplexes. Bisignate CD spectra of BR complexed with HSA and BSA showed complete inversion upon addition of chloroform 
•rroborating earlier findings. On the other hand, changes observed with BR-RSA complex were slightly different showing an 
iditional CD band of weak intensity centered around .^ 90 nm though inversion of CDCEs was similar to that of BR-HSA complex, 
onosignate CD spectra of BR-PSA complex also showed three CD bands occuning at 409. 470 and 514 nm after chloroform 
Idition. These results indicated significant but different effects of chloroform on the conformation of bound BR in BR-albumin 
implexes which can be ascribed to the changes in the exciton chiralil) of bilirubin probably due to altered hydrophobic 
icroenvironment induced by the binding of chloroform at or near the ligand biiiding site. Chloroform severely quenched the intrinsic 
/ptophan fluorescence of the protein and shifted the emission maxima towards blue region in all the albumins except PSA. However, 
lantitative differences in both quenching and blue shift were noted in different .serum albumins. This suggests that chloroform 
obably binds in the close vicinity of tryptophan residue(s) located in subdomaintsi Il.A or IB and II both. The fluorescence of 
R-albumin complexes was also found to be sensitive to the presence of a small amount of chloroform. But the changes observed in 
e fluorescence of the bound pigment in presence of chloroform were less marked as compared to the changes in the intrinsic 
jorescence of protein per se. Taken together, these results suggest that there is at least one conserved site for chloroform binding in 
1 these albumins which is at or near the BR binding site. © 2000 Societe frangaise de biochimie et biologic moleculaire / Editions 
tientifiques et medicales Elsevier SAS 
ilirubin / serum albumins / chloroform / CD inversion / chirality / fluorescence quenching 
. Introduction 
Bilirubin (BR), a catabolic product of hemoglobin 
'hen produced excessively in plasma, results in the 
evelopment of hyperbilirubinemia leading to a perma-
ent neurologic disorder, kemicterus, in newborn infants 
1]. Albumin acts as a biologic buffer against life thieat-
ning neurotoxic effects of BR which in a non-covalent 
ssociation transports it to the liver for conjugation and 
ubsequent excretion from the body [2. 3]. The study of 
iR binding to albumin has been a long term discussion 
ecause of its use in developing various preventive 
leasures against fatal kemicterus in jaundiced infants [4]. 
'arious serum albumins have shown differences in the 
inding of BR to high affinity site as characterized by 
Correspondence and reprints: bii.samua@nde.\ snl.net.in 
* Present address: Department of Biochemistry and Molecular 
(iology. Medical College of Georgia, Augusta GA 30912. USA 
different techniques including fluorescence and circular 
dichroism (CD) spectroscopy [5. 6]. Both spectral prop-
erties (CD and fluorescence) of BR-albumin complexes 
have been shown to be affected by change in the experi-
mental conditions such as pH or presence of chloroforin 
[6. 7]. The study of the effect of chloroform on the spectral 
properties of BR-albuinin complex becomes important 
due to its use in the extraction of various BR isomers after 
photoinadiation of BR-albumin complex under in vitro 
conditions [8. 9] as well as its use in solubilizing BR in 
BR-albumin binding studies [6]. Non-specific association 
of chloroform with serum albumins and other proteins has 
been well documented [10]. The inajority of proteins have 
been found relatively insensitive but for those which are 
sensitive, a trace amount of chloroform and other anes-
thetic molecules though has been shown to have little 
effect on secondary and tertiary structure but sufficient to 
perturb their normal functions [10-13]. This is evident 
from the chloroform dependent inversion of the charac-
teristic bisignate CD spectrum of BR-HSA complex as a 
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Abstract 
In order to study the involvement of lysine residues of human serum albumin (HSA) in the binding of indomethacin. HSA was 
treated with different molar excess of acetic anhydride, succinic anhydride and C-methylisourea which resulted in differently 
modified preparations: 30%, 62%. and 87% acetylated, 20%. 34%. 64% and 78% succinylated and 21%. 43% and 86% guanidinated 
HSAs. All the preparations were found to be homogeneous with respect to charge as well as size as judged by polyacrylamide gel 
electrophoresis and gel filtration on a Seralose-6B column. Hxdrodynamic and circular dichroic results showed that pronounced 
conformational changes (both tertiary and secondary structures) were induced in the maximally acetylated (87%) and succinylated 
(78%) preparations. On the other hand, guanidinated preparations showed no expansion in the hydrodynamic volume. The 
percent decrease in a-helical content was 34% for 87% acetylated. 31" M for 78% succinylated and 10%. for 86% guanidinated HSAs. 
A significant increase in the values of Stokes radii and frictional ratios (from 3.43 nm and 1.29 for native HSA to 4.07 nm and 
1.52 for 87% acetylated and 4.35 nm and 1.60 for 78% succinylated HSAs. respectively) was also noticed in these highly modified 
preparations. Fluorescence quench titration results obtained at pH 7.4 and ionic strength 0.15 showed that only 54.1% and 64.7% 
binding of indomethacin at 4;1 drug/protein molar ratio was retained by 87% acetylated and 78%o succinylated HSAs. respectively, 
as compared to 91% retention in binding in 86%. guanidinated preparation. No reversal in the binding of drug to 87% acetylated 
and 78% succinylated HSA preparations was observed on increasing the ionic strength to 1.0. Therefore, it seems that one or two 
critical lysine residue(s) that can form salt linkage with the carboxyl group of indomethacin, was (were) probably modified in these 
preparations. A small decrease in the binding of drug to the guanidinated preparation also confirms the inyolvement of positive 
charge, probably contributed by lysine residue(s). in the binding of indomethacin to HSA. © 1999 Published by Elsevier Science 
B.V. All rights reserved. 
AViiiorrf.v; Acetylation; Guanidination; Human serum albumin: Indomethacin: Succinvlation 
1. Introduction 
Human serum albumin (HSA) is the major transport 
protein of the mammalian blood circulation. Its ability 
to bind a broad spectrum of ligaiids, both exogenous 
and endogenous, seems to be correlated well with its 
structural flexibility to adopt its shape to the Hgand [1]. 
Of particular pharmacological interest is the binding of 
drugs to serum albumin, most of which bind to this 
protein in a reversible manner. A detailed knowledge 
* Corresponding author. Tel.: +91-571-401718: fax: -1-91-571-
401081. 
E-mail address: btisamu(g,x400.nicgw.nie.in (S. Tayyab) 
about the drug binding site is necessary to understand 
the distribution of any drug in the body and its compe-
tition with other drugs or with a natural catabolite, 
bilirubin [2], since the pharmacokinetic behaviour of 
drugs can be greatly dependent on the binding phe-
nomenon [3]. Binding of indomethacin, a pharmacolog-
ical agent used to promote constriction of the patent 
ductus arteriosus in premature infants, to HSA has 
been shown to be competitive in nature and utilizes 
both the bilirubin and diazepam binding functions of 
serum albumin [4-6] . N o attempt regarding the in-
volvement of various amino acid residueis of HSA in 
the binding of indomethacin has yet been made to the 
best of our knowledge. On the other hand, involvement 
0141-81.^ 0 99 S - see front matter C 1999 Published bv Elsevier Science B.V. All rights reserved. 
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In order to characterize in terms of bilirubin binding, 
major proteins in the goat brain were separated into 
five different pealu, namely PQ, PI, P21 P3 and P4 on a 
Seralose-6B column (90.5 x 2.5 cm). The peak Po was 
eluted with the void volume of the column. The 
molecular weights and Stokes radii of the remaining 
peak proteins were: Pi (1,06,727 and 4.11 nm), P2 
(59,256 and 3.25 nm), P3 (18,713 and 1.71 nm) and P4 
(11,928 and 1.14 nm). Bilirubin binding studies indi-
cated that three out of the five peak proteins, namely 
Pi, P2, and P3 showed bilirubin binding as charac-
terized by the blue shift and hyperchromism in the 
visible absorption spectra and quenching of the 
protein fluorescence upon addition of bilirubin to 
these peak proteins. 
HYPERBILIRUBINEMIA is an important pathological 
condition in the newborn and the possibility of low grade 
brain damage due to bilirubin toxicity is of interest 
to clinicians'. Decreased albumin binding capacity, 
increased bilirubin concentration or low albumin levels, 
can account for increased bilirubin deposition in the brain 
thus leading to the development of the clinical syndrome, 
kernicterus which may result in infant death .^ Bilirubin 
neurotoxicity may be mediated by a number of mecha-
nisms due to its increased permeability in neuronal 
membranes. Recently, it was reported that the high 
neonatal serum bilirubin levels adversely affected 
hearing', while in newborn piglets its prolonged infusion 
modified the N-methyl-D-aspartate (NMDA) receptor/ion 
channel complex in the cerebral cortex". In spite of 
extensive research, the mechanisms of bilirubin toxicity in 
the brain and characterization of the bilirubin binding 
proteins remain elusive. In this paper, we report our data 
on the characterization of some bilirubin binding proteins 
in goat brain. 
Fresh goat brain, obtained from a local slaughterhouse, 
was dissected and made free of membranous tissues and 
circulatory debris. Then, it was cut into small pieces and 
homogenized in a Remi mixer for about 5 min with 
three volumes of 0.06 M sodium phosphate buffer, 
pH 7.0. The crude homogenate was centrifuged at 6(X)0 g 
for 30 min. The supernatant was filtered through milli-
pore filter (0.25 mm) and the residue was discarded. It 
was then applied directly on a Seralose-6B column 
(90.5 X 2.5 cm). The different peak fractions, obtained 
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Visualization of serum albumin on electrophoretic 
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Abstract 
Serum albumin, when incubated with bilirubin prior to electrophoresis, was visualized as a 
yellow-colored band during the electrophoretic run and did not require any staining. Furthermore, 
free bilirubin served as a tracking dye. A minimum of 20 p,g of protein was detected very well by 
this method. The formation of a bilirubin-albumin complex did not affect the electrophoretic 
mobility as the protein complexed with bilirubin as well as free albumin moved with the same 
mobility. Only a single protein band was visualized by this method after electrophoresis of human 
plasma. The method is simple, less time-consuming and may be used in identifying bilirubin-
binding proteins in various biological samples. © 1998 Elsevier Science B.V. All rights reserved. 
Keywords: Bilirubin; Electrophoresis; Human serum albumin 
1. Introduction 
Bilirubin, a catabolic product of hemoglobin, is toxic in its free form to various cell 
types [1,2]. Under normal physiological conditions, the toxicity of this substance is 
checked by albumin, which carries it to the liver for conjugation with glucuronic acid 
and excretion [3]. However, when the production of bilirubin exceeds the binding 
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